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Abstract 
Breast cancer, a complex and debilitating disease, is responsible for the highest rate of 
women mortality compared to other cancers worldwide. Advances in information 
technology and activities such as ‘breast cancer awareness month’ have created greater 
breast cancer awareness and its impact. The increase in breast cancer awareness has 
increased the number of women who wanted to know about their risk to breast cancer. 
As a variety of factors influence a breast cancer development in women, an important 
research question is how to accurately identify the risk of breast cancer given some 
known factors. The increase in breast cancer awareness has increased the number of 
women undertaking breast cancer screening. It is therefore not surprising that there has 
been a dramatic increase in the number of women diagnosed with breast cancer. For 
women with breast cancer, they are concerned with their chances of survival outcomes 
and cure after treatment. Therefore, knowing the survivability period that matters most 
to women with breast cancer remains an open challenge. Recurrence of the cancer is 
another concern in breast cancer survivors. Although breast cancer survival rates have 
been improving and many more patients are living longer, breast cancer can reoccur at 
any time after treatment. Therefore, the third most common question that women want 
to get an answer for is the chances that the cancer will return following treatments. The 
answer to this question is very important both to the patient and the medical practitioners 
treating the patients for the purpose of determining additional treatment decisions. In 
this regard, this thesis addresses the following three critical challenges:  
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(i) how to predict the risk of breast cancer by finding the most informative set of 
genes?  
(ii) how to evaluate precisely the probability of breast cancer recurrence among 
breast cancer patients? and  
(iii) how to estimate survival outcome of breast cancer patients who underwent 
surgery treatments within five years or longer?  
Answers to the above questions are critical for making appropriate and successful 
treatment regime and decisions as well as enabling breast cancer patients to have 
quality of life. To this end, this thesis makes the following contributions: 
(i) For predicting the risk of developing breast cancer, an ensemble classifier with 
correlation-based feature selection and a forward search has been developed and 
evaluated using microarray breast cancer gene expression datasets. The 
proposed ensemble classifier helps to classify the relapse with the most 
informative genes, which can help physicians to identify breast cancer at the 
early stages. The proposed ensemble-based classification method showed 
higher classification accuracy compared to other popular approaches.  
(ii) For predicting breast cancer recurrence, an approach that coupled Deep Neural 
Network and Random Forest classifiers to predict survival status of breast 
cancer patients who underwent surgical treatment within five years or longer 
was developed and evaluated using Haberman's Survival dataset from 
University of Chicago's. The experimental results indicated that the approach 
suggested in this study can considerably enhance breast recurrence accuracy 
compared to existing models. The experimental results obtained from the sub-
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problems in this thesis demonstrate improving machine learning methods to 
solve complex biological challenges. 
(iii) For predicting breast cancer survivability, we a model based on a Random 
Forest and a Deep Neural Network is developed and evaluated using the 
Wisconsin Prognosis Breast Cancer dataset obtained from UCI repository. The 
results of the experiment in the model achieved the highest accuracy compared 
to exiting models.  
These outcomes will facilitate better clinical decision-making that include significant 
inter-individual variability in diagnosis, developing data-driven efficient and reliable 
tools that can help oncologists in identifying and validating novel risk factors as well 
as predicting survivability and recurrence of breast cancer.  
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Chapter 1: INTRODUCTION 
1.1 Background 
In recent years, breast cancer has emerged as the most prevalent cancer affecting women 
in both developing and developed countries. Cancer is described as number of disorders 
that consist of numerous unusual cells, which spread in the body. Many factors such as 
rise in life expectancy, increased urbanization, and adapting of western lifestyles in 
developing countries have contributed to greater risk of breast cancer incidence. It has 
been found that breast cancer is usually diagnosed in very late stages in middle-income 
countries, and because of this the majority of breast cancers in such countries cannot be 
eliminated even by using prevention strategies [1]. In 2018 over 2 million new cases 
have been diagnosed with breast cancer globally [2]. Today, cancer kills more low and 
middle-income people than AIDS, tuberculosis, and malaria combined [3]. Globally, in 
2018 about 627,000 females died due to breast cancer. The World Health Organization 
(WHO) has reported that cancer is the leading cause of death and accounts for  
approximately 15% of all deaths globally [1]. 
Cancer represents number of diseases containing many abnormal cells, which are 
not destroyed normally by the body, and which spread out of control. Different cancers 
can be differentiated based on type of cell and location in the body [4]. The human breast 
is a complex organ and passes through many physiological changes from birth, to 
puberty, pregnancy, and breast feeding until; menopause. Due to hormonal changes in 
the breast during a woman’s life, many changes occur. Breast tissue spreads from 
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different body parts such as the collarbone, to lower ribs, sternum (breastbone), and 
armpit. The human breast includes between 15 and 20 parts known as lobes, which are 
responsible for producing milk for the breast feeding female. These lobes are linked to 
one nipple through 6 - 8 tubes known as ducts, which transport the milk to each nipple. 
Lymph nodes and vessels in the breast and armpit, which are chunks of immune system, 
carry the lymph fluid and white blood cells. The other parts of the breast represent fatty 
tissue.  
 
Figure 1.1 Anatomy of the female breast 
 
[Source: https://nbcf.org.au/about-national-breast-cancer-foundation/about-breast-cancer/] 
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Figure 1.1 shows the lobe, lobules, ducts, and the other parts of the female breast [5]. 
Technically, cancer is defined as “a family of diseases involving uncontrolled cell 
growth wherein cells divide and grow exponentially, producing malignant tumours, and 
spreading to other parts of the body”.  
Cancer is destructive because it has the ability to spread to the neighbour tissues, and 
more worrying, to the whole body by way of the lymphatic system or bloodstream.  
Hundreds of cancers have been documented to exist in the human body [6]. Due to the 
fact that there are literally countless causes of cancer, researchers have still to fully 
understand the basis of cancer. Nevertheless, what is known for sure is that a healthy 
cell will become a cancer cell when there is modification of the genes which control cell 
growth and differentiation [7]. 
Despite the fact that medical science has made tremendous advances, cancer 
continues to grow at an alarming rate. According to the Cancer Council of Australia, the 
number of new cancer cases in Australia for 2019 is estimated to be about 126,800 and 
this number is expected to increase to 150,000 by 2020 [8, 9]. Cancer treatment costs 
are estimated to exceed US $4.5 billion in direct health system costs. It is predicted  that 
to be effective  the healthcare system must be able to prevent, predict, preempt, and be 
precise [10] to improve the quality of patient care without significantly increasing cost. 
Over the last few years, remarkable advances in medical science have been achieved, in 
the effort to provide better and earlier detection, prediction, and treatment so that there 
can be a better quality of life for cancer patients.   
Despite the fact that cancer can result in a positive outcome if detected early, the 
reality is that most cases are diagnosed at the later stages. It is also common for cancer 
7 
 
to come back even after years of treatment. Cancer recurs because tiny portions of cancer 
cells may stay undetected in the body following treatment. Therefore, the early diagnosis 
and prognosis of a cancer are now deemed as crucial in cancer studies.  
An interesting and challenging research is how to predict cancer occurrence and 
recurrence risks as well as early prediction of cancer treatment outcomes. This line of 
research is active but remains unresolved. This is especially true for breast cancer 
research, which is the focus of this study.   
 Researchers apply efficient machine learning tools to construct models and 
approaches that may help doctors in the process of investigation and therapy. However, 
in some cases, women develop breast cancer that becomes distantly metastasized, which 
is common in the late stages, and consequently, offer low survival rate. Survival rates 
for breast cancer are not uniform based on the cancer type, stage at detection, therapy, 
and geographical location of the patient. For instance, survival rates are high in Western 
countries whereas in developing countries survival rates are significantly lower. As 
such, this research offers a possibility, that this study together with related future work 
could contribute new knowledge that can facilitate better diagnosis of breast cancer 
globally. Although several studies have been undertaken recently, in this area, but there 
is still a need for more robust breast cancer risk assessment, survivability, and recurrence 
prediction approaches to improve the survival rate of patients or which can reduce the 
high costs involved due to unnecessary treatments by allowing the selection of 
individualized therapies. 
This chapter begins with a presentation of the background and basic concepts 
relevant to this thesis. The research problem is then stated followed by the research 
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objectives, the significance of the study and the research methodology are then presented 
and explained, the significance of the study and then the organization of the thesis 
conclude the chapter.   
1.2 Problem Overview 
The research on cancer management needs to tackle many challenges, which includes 
the following inter-related problems [11]: 
i. Assessing breast cancer risk - Every person is at risk for cancer. Genetic factors 
affect a person’s risk; many genes have high impact and are responsible for 
causing breast cancer. An important challenge addressed in this thesis is how to 
identify accurately the risk of breast cancer based on the most informative genes 
with respect to the chances of developing a cancer in the near future. 
ii. Evaluating breast cancer recurrence assessment Cancer recurrence is defined 
as the return of cancer after a period post-surgery treatment when the cancer is 
undetectable. The same cancer may recur where it originally started or elsewhere 
in the body. Such recurrence can happen from as soon as weeks or as long as 
several years post treatment. The challenge this study addresses is how to predict 
accurately the probability of cancer recurrence for patients within a five-year 
period or longer post- surgery treatment.  
iii. Predicting the breast cancer survivability status Cancer survivability 
assessment involves determining the expected survival time for a patient with 
advanced cancer. Survival statistics for cancer are usually written as one-year 
survival, five-year survival or ten-year survival. These statistics can sometimes 
be difficult to determine.  
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The challenge addressed in this study is how to predict survival status of breast 
cancer patient’s post-surgery treatment within five years or longer. 
In summary, the above three challenges present significant gaps in the literature 
which form the bases of this study. The first case involves an attempt to predict the 
likelihood of developing a type of cancer before the disease occurs. The second case 
focuses on the possibility of the cancer recurring after it has been apparently contained.  
The third case is the attempt to estimate the survivability status of breast cancer patient’s 
post-surgery treatment after the diagnosis of the disease.  
In light of the above, there is ongoing research to address clinical and societal 
challenges of breast cancer globally. The overall aims of this thesis are to scrutinize 
existing risk assessment, survivability, and recurrence approaches for breast cancer.  
Figure 1.2 presents an overview of the research problems.   
?
Prognosis
Treatment
Follow-up
T1 : RecurrenceT1 : Remission
Output 2
T0 : Diagnosis
?
Output 3
?
Optimal 
Features
Output 1
Clinical data
Low risk High risk
cancer
 
Figure 1.2 Overview of research problems  
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1.3 Research Objectives 
The cure, survivability and risk assessment of breast cancer have a direct realtionship 
with  the time of detection and diagnosis. The earlier the detection of the breast cancer 
the better the prognosis of the cancer. As a result, breast cancer remains a substantial 
scientific, clinical and societal challenge. There has been  active research on  early 
detection of breast cancer worldwide. The general aim of this thesis therefore is to study 
the problem of breast cancer prediction and develop an efficient solution that guarantees 
an accurate predictive model. 
The specific aims of this research project include:   
i. Assessing accurately the breast cancer risk based on microarray expression 
genes. 
ii. Evaluating the probability of breast cancer recurrence depending on the 
outcome attributes within a five-year period or longer post-treatment.  
iii. Predicting the survival status of breast cancer patients post treatment within 
a five-year period  or longer. 
1.4 Research Questions  
In light of the research obejctives outlined above, the following research questions are 
formulated:  
Question 1:  
How to assess the risk of getting breast cancer based on gene expression breast 
cancer data? 
Question 2:  
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How to evaluate breast cancer recurrence with high level of confidence post-
surgery treatment? 
Question 3:  
How to predict the survivability status of breast cancer patient’s post-surgery 
treatment? 
1.5 Thesis Significance  
The fundamental goals of cancer prediction and prognosis are distinct from the goals of 
cancer detection and diagnosis. Depending on the type of cancer, recurrence can occur 
weeks, months, or even many years after the primary cancer was treated. It is extremely 
difficult for physicians to know which cancer patients will experience recurrence. The 
likelihood that a cancer will recur, and the likely timing and location of a recurrence 
depend on the type of the primary cancer. Some cancers have a predictable and 
distinguishable pattern of recurrence, which can be picked up by pattern recognition and 
machine learning techniques. Therefore, an efficient way for prediction of cancer 
recurrence is required to manage the cancer and subsequently improve the quality of 
patient care.  
Survivability analyses mainly deal with application of various methods to historic 
data in order to predict the survival of a particular patient suffering from breast cancer 
over a particular time. It is well known that the prediction of breast cancer survivability 
is a challenging research problem and developing prediction models for breast cancer 
survivability is a significant undertaking. The ability to accurately and reliably predict 
the risk of cancer in average-and high-risk individuals is important in preventing the 
development of cancer and to ultimately advance clinical practice in the early detection 
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of cancer. This is very significant in saving lives and in the reduction of cancer related 
healthcare costs. 
1.6 Thesis Contribution  
This study focuses on the development of a hybrid approach that combines various 
machine learning approaches to exploit their predictability strengths while avoiding 
their weaknesses to address the challenges of risk assessment, survivability and 
recurrence of breast cancer and in so doing, will offer the following contributions: 
i. The development of a new reliable prediction approach to breast cancer risks 
to assess breast cancer risks using the most informative genes related to 
breast cancer. The ability to accurately and reliably predict the risk of breast 
cancer is important to prevent the development of cancer and to ultimately 
advance clinical practice in the timely detection of cancer. Physicians face 
serious challenges when it comes to the issues of cancer risk assessment due 
to a wide variety of influencing genes.  
ii. The development of a new predictive approach for breast cancer recurrence 
that reliably estimates breast cancer recurrence based on the outcome class 
label attribute such as (R, N) within a five-year period or longer post-surgery 
treatment. Cancer recurrence is the major cause of death in cancer patients. 
Therefore, the early identification of cancer patients at higher risk of relapse 
post-surgery treatment will help medical practitioners in selecting patients 
to be considered for additional treatments early and to better control the 
impact of recurrent cancer on survival.  
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iii. The development of a new predictive model for breast cancer survivability 
to predict breast cancer survivability status post-surgery treatment within a 
five-year period or longer. With respect to breast cancer survivability, the 
best time estimate that the medical practitioners can give currently, 
depending on the cancer type and patients’ clinical data, is a five-year 
survival rate ratio. It will be helpful to develop an algorithm that will enable 
medical clinicians to provide more accurate and less invasive prognosis of 
cancer survivability.  
1.7 Research Methodology 
This thesis employed experimental analyses, which is common methodology used to 
investigate and validate the breast cancer issues such as risk assessment, predicting 
survivability status and evaluating recurrence outcomes. The machine learning methods 
proposed in this study involved various data mining processes beginning with proper 
data collection, of publicly available online datasets, as individual approaches are used 
in research of this magnitude to study the efficacy of the proposed solutions, evaluating 
of experimental results employing tables and graphs. Details of every step are explained 
in each chapter.  
With the availability of novel technologies in the field of medicine, there is a 
substantial volume of cancer data collected and available to the medical research 
community. In this study, analysis was done of the collected publicly available 
microarray of breast cancer gene expression datasets [12] to predict the probability of 
breast cancer risk based on the most informative genes. A feature selection method was 
used for the reduction of the dimensionality of the gene dataset. The reduced features 
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were used with the ensemble classifier, which contains three classifiers such as Deep 
Neural Network (DNN), Support Vector Machine (SVM), and Random Forest (RF), to 
train and predict the relapse of the breast cancer data. The proposed ensemble classifier 
would help to classify the relapse with the most informative genes, which could assist 
physicians to assess breast cancer risk at the early stages. In this study, the mean and 
standard deviation of the accuracy, recall, and precision metrics were calculated.  
For the purpose of this study, the publicly available Wisconsin Prognostic Breast 
Cancer (WPBC) dataset was examined [13]. It contains 35 attributes and 198 instances 
including 151 non-recur, and 47 recur cases. In this study, the most widely used 
classification models such as Random Forest (RF) and Deep Neural Network (DNN) 
were to predict the probability of breast cancer recurrence among breast cancer patients 
to reduce the probability of death. Accuracy, precision, and recall metrics were utilised 
to evaluate the test data.  
This study also investigated Haberman’s Survival dataset ,which is publicly 
available from UCI machine learning repository [14]. This dataset is imbalanced data, 
which consists of 306 samples with four numerical variables such as the age of a patient 
at the time of operation, ranging from 30 to 83 years. Deep Neural Network and Random 
Forest classifiers were individually applied to predict survival status of breast cancer 
patients who underwent surgery treatment within five years or longer. Several 
performance metrics were used such as Accuracy, Sensitivity, and Specificity to 
measure model performance. 
1.8 Organisation of the thesis 
Following is a brief overview of the rest of the thesis: 
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Chapter 2 presents a comprehensive literature review on breast cancer prediction 
models, existing methods related to breast cancer risk assessment, survivability, and 
recurrence prediction, along with existing prediction approaches. The review is also for 
the purpose of identifying the existing problems and any new and significant study 
issues. In addition, this chapter will investigate challenges that remain open. 
Chapter 3 provides a mechanism to assess the breast cancer risk. The main concept 
of this approach is to identify the most informative genes “AB020713” accurately, 
which may cause breast cancer. 
Chapter 4 presents a classification model to evaluate accurately the probability of 
breast cancer recurrence among breast cancer patients based on the time attribute within 
a five-year period or longer post-surgery treatment.  
Chapter 5 introduces and explains a predictive model to estimate accurately 
survivability status for breast cancer patient’s post-surgery treatment within a five-year 
period or longer.  
Chapter 6 summarizes the major findings of the study and discusses the 
accomplishments of this work, highlighting the limitations of this work and related future 
research directions. 
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Chapter 2: LITERATURE REVIEW 
Cancer is considered a varied disorder containing a number of subtypes. The early 
detection of breast cancer has now become essential in cancer investigation. 
Researchers, doctors, and patients in the field of breast cancer prevention may use many 
risk assessment, recurrence, and survivability models to predict breast cancer outcomes. 
The classification of breast cancer patients is important because it defines the groups in 
terms of high or low risk. In the field of bioinformatics, a range of machine learning 
models have been investigated and variously employed as a part of cancer treatment. 
Moreover, machine learning approaches such as Decision Trees (DTs), Bayesian 
Networks (BNs), Support Vector Machines (SVMs) and Artificial Neural Networks 
(ANNs) are able to identify key attributes from complicated data indicate their 
significance. These techniques have been commonly employed in breast cancer research 
to develop a number of predictive methods, which can accurately assist in decisions 
related to breast cancer treatment. This chapter reviews the latest machine learning 
methods utilised in breast cancer research. The predictive models presented in the 
literature are based on various breast cancer datasets and outcome attributes.   
2.1 Background  
In the last few decades, there has been ongoing development associated with breast 
cancer research has achieved much [15]. Researchers employed various models, for 
instance, cancer screening in the early stages to detect sorts of cancer before symptoms 
of the disease are manifested. Furthermore, there has been the development of new 
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strategies for the accurate prediction of breast cancer therapy outcomes at the early 
stages. With the advent of new medical strategies, massive amounts of breast cancer 
data have been gathered and are publicly accessible by medical researchers. However, 
the most challenging task for doctors is how to accurately predict breast cancer. 
Accordingly, in medical research, the machine learning approaches have become very 
widely used. These methods can determine and categorise relationships among them, 
from compound datasets, and accurately predict future consequences of a breast cancer. 
In breast cancer prediction / prognosis, there are three prediction concerns: 1) predicting 
cancer risk assessment; 2) predicting cancer recurrence, and 3) predicting cancer 
survivability. The first case involves the prediction of the possible development of a 
type of cancer before the disease occurs. The second case involves the prediction of 
possible recurrence of the cancer after it has apparently been resolved. The final case 
involves the prediction of survivability status post diagnosis of the disease. In the second 
and third cases, the success of the prognostic prediction is clearly linked partly to the 
success or quality of the diagnosis. On the other hand,  a disease prognosis is only 
possible  following a medical diagnosis and a realistic prognostic prediction is not 
possible with  a simple diagnosis but requires more [16].  
Machine learning approaches could enhance the accuracy of predicting cancer risk 
assessment, recurrence, and survivability [17]. According to [18], in the last few years, 
15% - 20% of the prediction accuracy of cancer outcome has been improved by using   
machine learning methods. The most challenging study is how to predict breast cancer 
outcomes at early stages. This line of research is still active but remains vague. In this 
chapter, it has been found that several experiments stated in the literature have their 
18 
 
basis in various strategies that are used in breast cancer risk assessment, and prediction 
at early stages [19-27].  
In addition, this study has reviewed a number of papers related to the recurrence of 
breast cancer within different periods [28-33]  and also reported a few studies focusing 
on the predicting of breast cancer survivability based on various outcomes [11, 34-38].  
Figure 2.1 demonstrates that one expects a coordinate system, which represents the 
shape and orientation of breast tissue structure more accurately on mammogram than in 
conventional Cartesian coordinate system used so far. 
 
Figure 2.1 Shape of breast tissue structure 
[Source:  https://www.cancer.org/cancer/breast-cancer/if-you-have-breast-cancer.html] 
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2.2 Cancer risk assessment prediction models 
Although several studies have been carried out recently in this area but still there is a 
need for more robust breast cancer risk assessment prediction approaches that can 
enhance the survival rate of patients or which can reduce the high costs involved with 
unnecessary treatments by allowing the selection of individualized therapies. Although, 
the risk of being identified with breast cancer is broadly estimated, the lifetime risk 
varies between one in eight and one in twelve. Also, the possibility  of  a 10-year risk in 
any given period of life is not more than one in twenty-five [39]. Furthermore, a number 
of additional risk factors, for instance, endocrine factors, family history, and host factors 
containing the density of the breast and benign proliferative history of breast disorders, 
can significantly alter the risk of developing breast cancer. Except for age, a family 
history of breast cancer is possibly the most significant risk factor for the development 
of this disease. 
There has been the development of a sizeable number of risk prediction models 
which have examined a range of various risks for the development of breast cancer. The 
aim of current breast cancer prediction is to identify genes, which are responsible for 
causing breast cancer by using machine-learning tools. The work of Abd-el Fattah, et al. 
[19], classified microarray gene expressions colon dataset by using different machine 
learning methods such as K-Nearest Neighbour (KNN), Decision Tree (DT), Support 
Vector Machine (SVM) and Naive Bayes (NB). They identified suitable patterns, which 
could help classify tumours, and various disease states, as well as discover new disease 
forms. However, such a study poses the challenge of a low number of observations. The 
imbalance in the dimensionality increases the complexity of algorithms, which are 
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designed to study and analyses the higher order gene expressions. KNN shows better 
accuracy of 88.7% compared to other classifiers in the experiment. 
Singh and Sivabalakrishnan [20] presented the most recent machine learning method 
based on microarray data. They reported that classifiers tend to perform poorly due to 
the lower sample size. This research requires certain features such as filtering criteria, 
which can help in identifying suitable informative genes, thereby improving the 
performance of classifier algorithms. Juliusdottir et al. [21] reviewed feature selection 
methods based on microarray data cancer classification such as SVM. They identified 
key features which could help to better analyses molecular-based cancer, a discovery of 
newer drugs, and early detection of cancer. However, their study was limited to SVM 
only. 
Hu, et al. [22] conducted their experiments on four popular genes selection ranking 
methods, namely correlation coefficient (CC), Cosine (CO), Euclidean (EU), and Noise 
ratio (SNR) by using microarray breast cancer data. The classification was performed 
with SVMs and decision trees (C4.5) and Support Vector Machines (SVM). In their 
study, the genes were individually identified based on their deferential distribution of 
expression levels across pre-defined labels and then sorted in a decreasing order of 
importance. Using a suitable filtering threshold, the genes were selected when the 
minimum significance selection criteria were satisfied. SVMs have shown up to 15% 
improvement in prediction accuracy among four gene selection methods. 
The highest accurate results are based on 20 genes, with CC and SN methods 
showing higher electiveness of pre-processing with an average of 0.77% accuracy.  
These feature selection algorithms are very intuitive and simple to implement.  
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Mazlan and Saad [23] applied Relief-F, Information Gain and Chi-Square 
algorithms,  for feature selection based on microarray breast cancer data, which was also 
mentioned by Kononenko [24]. They proposed Radial Basis Function (RBF) Network 
as a classifier to differentiate the cancerous and non-cancerous cells. This algorithm 
shows more robustness in terms of noisy high-dimensional multi- class gene expression 
data than the original Relief feature selection algorithm [25]. However, [40] could not 
deal with noisy data and multi-class gene expression datasets. This study uses Receiver 
Operating Characteristic (ROC) to evaluate the classifier performance. RBNF shows 
best classification accuracy with 0.94% based on 50 top-ranked genes of breast cancer 
microarray data. 
According to Ebrahimpour et al. [25], the other selected genes could be analyzed 
using a new method of feature selection with maximum correlation and minimum 
redundancy (MCMR). They applied their method to breast cancer dataset of 5,166 genes, 
among them 44 low risk tumour samples and 33 high-risk cases. They used several gene 
selection methods, for example, SVM, KNN (k-Nearest Neighbourhood), and a method 
of classification using minimum distances to Mean C. They also compared the results 
by calculating the rate of accuracy based on a 10-fold cross validation (CV) in two 
iterations. The best accuracy rates achieved were 0.87.56 % ±1.5%, among four gene 
selections.  
Saberkari et al. [26] utilised selective independent component analysis (SICA) to 
identify the best informative genes from microarray data. They solved the issue of 
instability in conventional independent component analysis (ICA) methods. Initially, the 
components of the genes were analyzed independently using reconstruction error and 
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selective set, by ensuring minimum interference in inducing errors while reconstructing 
a new sample. Then, modified SVMs (SVM) were simultaneously used to train sub-
classifiers. Finally, the classifier with the best recognition accuracy was selected. This 
algorithm was also applied to breast cancer microarray dataset, which consisted of 97 
samples from microarray tests with 24,481 gene expression levels. The data were 
divided into two groups. In the test process, 19 control samples were used (with 12 cases 
relating to relapse samples and seven cases relating to non-relapse samples). In the 
training process, 78 cancer samples were used (with 34 cases relating to relapse samples 
and 44 cases relating to non-relapse samples). The results of their proposed method 
revealed 74.67% accuracy for the breast cancer microarray datasets. They achieved this 
using feature selector with support vector machine-recursive feature elimination (SVM-
RFE) and relaxed linear separability (RLS). 
Kreawczuk and Lukaszuk [27] presented a very recent work that could help in 
identifying suitable genes in lower dimensional spaces. They used microarray breast 
cancer dataset, which consisted of 24,481 genes and 97 samples. After the feature 
selection process, SVM along with convex and piecewise linear (CPL) were considered 
as classifiers. A 10-fold CV was used, and the higher accuracy rate achieved was equal 
to 73.20%. 
The current research is yet to identify the root cause of cancer. Doctors confront 
significant challenges when it occurs to the issues of cancer risk assessment due to a 
widespread range of affecting genes. Machine learning based prediction has been most 
often used to determine the risk of getting breast cancer. An accurate assessment of the 
risk can lead to more successful treatment, avoid unnecessary toxicity, save lives, and 
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reduce cost [41]. Therefore, there is a need to develop a reliable and accurate model for 
making decisions regarding breast cancer risk. Table 2.1 shows that none of these papers 
[19-27] have a smaller number of genes and higher accuracy rate compared to the 
proposed evaluation method using the ensemble classifier. 
Table 2.1 Summary of cancer risk assessment prediction models 
Authors Method Type of data No. of Genes 
Abd-el Fattah, et al. 
2013 
KNN, J48, SVM and 
NB 
Microarray gene 
expressions colon 
dataset 
10 
Singh & 
Sivabalakrishnan, 2015 
 
Filter and Wrapper 
methods 
 
Microarray gene 
expressions 
dataset 
Unknown 
Juliusdottir, et al., 2005 SVM Microarray gene 
expressions 
dataset 
 
37 
Hu, et al., 2006 SVMs and C4.5 Microarray gene 
expressions breast 
cancer dataset 
20 
Mazlan & Saad, 2012 Radial Basis Function 
(RBF) Network 
Microarray gene 
expressions breast 
cancer dataset 
50 
Ebrahimpour, et al, 
2013 
SVM, KNN Microarray colon 
and breast cancer 
dataset. 
 
33 
Saberkari, et al., 2014 Selective independent 
component analysis 
(SICA)+ modified 
support vector 
machine (υ-SVM) 
Microarray gene 
expressions breast 
cancer dataset 
Unknown 
24 
 
Kreawczuk and Lukaszuk, 
2016 
Relief-F, least 
Redundancy most 
relevance, support  
vector machine, 
recursive feature 
elimination and 
relaxed linear 
separability 
 
Microarray gene 
expressions 
colon, Leukaemia 
and breast cancer 
 
76 
 
2.3 Cancer recurrence prediction models  
Two linear programming medical applications are discussed by [42]. In particular, linear 
programming-based machine learning techniques are employed for the purpose of 
increasing the accuracy and objectivity of breast cancer diagnosis and prognosis. The 
first application to breast cancer diagnosis uses characteristics of individual cells, 
obtained from a minimally invasive fine needle aspirate, to differentiate benign from 
malignant breast lumps. This makes it possible to achieve an accurate diagnosis and thus 
making   a surgical biopsy unnecessary. The current diagnostic system used at University 
of Wisconsin Hospitals was trained on samples from 569 patients and has had 100% 
chronological correctness in the diagnosis of 131 subsequent patients. The second 
application, just introduced in clinical practice, is a method that constructs a surface that 
predicts the type of breast cancer with the highest likelihood to recur in patients whose 
cancers had been removed. This offers both physician and patient better information to 
facilitate the planning of treatment and possibly render a prognostic surgical procedure 
unnecessary. This new prediction technique can handle cases for which recurrence of 
the cancer has not taken place and also cased for which recurrence of the cancer has 
taken place at a specific time. The prognostic system has an expected error of 13.9 to 
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18.3 months, which is a better outcome compared to prognosis correctness using other 
available approaches. 
This review explains several studies on the breast cancer recurrence problem by 
applying different computational approaches and artificial neural networks. However, 
few papers are related to medical diagnosis and recurrence using data mining methods. 
This section focuses on the examination of some machine learning approaches to predict 
breast cancer recurrence.  
  Kim, et al. [28] studied  the performance of SVMs, ANNs, and the Cox regression 
methods to predict the recurrence of breast cancer within a five-year period post-surgery 
treatment. St. Gallen’s guidelines Nottingham Prognostic Index (NPI), and Adjuvant!  
Online were selected for assessing the effectiveness of the proposed methods. A total of 
679 patients participated. In this study, there were 195 recurrence samples, and 484 no-
recurrence samples. Seven attributes such as histological grade, tumour size, many 
metastatic lymph nodes, ER status, Lymph vascular Invasion (LVI), local invasion of a 
tumour, and many tumours were chosen from 193 attributes. Holdout method [28] (70% 
train –30% test data) was employed for evaluating the effectiveness of the classifiers.  
Accuracy, sensitivity, specificity, precision, AUC, and Negative Predictive Value 
(NPV) metrics were selected in this evaluation. SVMs outperformed all other 
approaches with 84.58%, 0.89%, 0.73%, 0.75%, 0.85%, and 0.89% respectively. ANN 
achieved 81.37%, 0.95%, 0.52%, 0.80%, 0.80%, and 0.82% while Cox produced lower 
rates of 72.55%, 0.24%, 0.94%, 0.63%, 0.73%, and 0.74%.  
Salama  et al. [29] estimated breast cancer recurrence by comparing the outcomes of 
DTs, MLP, SVM, NB, and KNN approaches. In this experiment, many breast cancer 
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imbalanced datasets were applied such as Wisconsin Breast Cancer (WBC), Wisconsin 
Diagnosis Breast Cancer (WDBC) and Wisconsin Prognosis Breast Cancer (WPBC), 
which were provided by the University Medical Centre, Institute of Oncology, and 
Ljubljana, Yugoslavia. In the case of classifying performance, the fusion between 
approaches was investigated, to determine whether the multi-classifier technique is 
beneficial or not. Ten-fold cross-validation technique was employed to assess the 
classifiers by evaluating their accuracy. SVM and DT achieved better performance 
compared to all other classifiers, producing an accuracy rate of 76.3%. MLP, KNN, and 
NB showed lower performance of 66.5%, 64.4%, and 50.5% respectively. SVM was 
combined individually with NB, MLP, DT, and KNN in the first fusion, while SVM and 
DT were combined independently with NB and MLP in the second fusion. Similar 
accuracy rate (76.3%) resulted for all combinations. SVM-DT-MLP-KNN and SVM-
DT-MLP-NB were combined in the third fusion. SVM-DT-MLP-KNN showed the 
highest accuracy rate of 77.3%, while SVM-DT-MLP-NB achieved lower accuracy rate 
of 74.2%.  
Tomczak [30] predicted breast cancer recurrence within a 10-year period post-
surgical treatment and identified the input symptoms related to breast cancer 
reappearance. In this experiment, Classification Restricted Boltzmann Machine 
(ClassRBM) learning methods such as DropOut, Drop Connect, and DropPart were 
applied. The performances of these methods were compared with those of Naive Bayes 
(NB), Support Vector Machine (SVM), Random Forest (RF), and Classification and 
Regression Trees (CART), and coupled with Adoboost, Bagging, and LogitBoost 
classifiers. The Institute of Oncology, Ljubljana provided 949 patients and 15 features 
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in this study, but not the breast cancer dataset. Holdout technique [30] (70% train set 
and 30% test set) was used for the evaluation of the effectiveness of the classifiers, while 
100 cases were used in the test data to predict from oncologists. LogitBoost + CART 
ensemble performed better than all other classifiers with accuracy rate of 75%, while, 
SVM showed poorer performance compared to other computational methods, which 
showed better performance than medical experts did.  
Chaurasia and Pal [31] assessed the performance of Dyadic Decision Trees (DDTs), 
Artificial Neural Network (ANN), and Logistic Regression (LR) classifiers to predict 
the recurrence status of breast cancer patients in a five-year period post-surgical 
treatment. The dataset in this experiment was provided by the University Medical 
Centre, Institute of Oncology, Ljubljana, Yugoslavia, and contained 10 features and 286 
samples. WEKA application was used in all experiments without tuning the parameters 
before or during the classification process. Ten cross-validation techniques were 
employed to determine the classifier metrics such as accuracy, specificity, and precision 
for recurrence and no-recurrence classes. In this study, recurrence class is the label class 
and the effect of the preferred attribute on recurrence prediction was analysed. LR 
outperformed all others with 74.5%, 92.5%, and 64.3%, versus 71.3%, 92%, and 54.3% 
of DDTs respectively, whereas ANN showed lower result rates of 73.8%, 88.6%, and 
58.9%.  
Beheshti  et al. [32] made a comparison of the performance of genetic approaches 
like Centripetal Accelerated Particle Swarm Optimization (CAPSO), Particle Swarm 
Optimization (PSO), Gravitational Search Algorithm (GSA), and Imperialist 
Competitive Algorithm (ICA) with Multi-Layer Perception (MLP). Nine datasets of 
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Hepatitis, Heart Disease, Pima Indian Diabetes, Wisconsin Prognostic Breast Cancer, 
Parkinson’s disease, Echocardiogram, Liver Disorders, Laryngeal 1 and Acute 
Inflammations were applied to those hybrid approaches. They reported that tuning the 
parameters of PSO approach was time-consuming. To address this issue, fewer 
parameters were used and 80% train and 20% test data technique was used for the 
evaluation of the effectiveness of the approaches. MSE, AUC, accuracy, sensitivity, and 
specificity metrics were employed for evaluation. CAPSO-MLP was found to be the 
best approach for unseen data, as it outperformed all other approaches with 0.170, 
0.63%, 80.3%. 52.3% and 83.4% respectively. GSA-MLP performed 0.167 of MSE, 
0.55 of AUC, and 79.3% of accuracy, 7.86% of sensitivity, and 80.23% of specificity, 
while; ICA-MLP resulted in 0.177, 0.57%, 78.3%, 43%, and 83% respectively. PSO-
MLP achieved 0.173, 0.60%, 78.3%, 43%, and 83%.  
Ojha and Goel [33] investigated the probability of breast cancer recurrence among 
patients within a five-year period post-surgery treatment. In this study, Wisconsin 
Prognostic Breast Cancer (WPBC) Data Set was used, which contained 198 samples and 
35 attributes. In this experiment, they compared the performance of different popular 
clustering approaches such as K-Means, EM, PAM, and Fuzzy e-means and 
classification methods for instance C5.0, KNN, NB, and SVM. They divided the data 
set into 70% train data and 30% test data for the evaluation of the effectiveness of the 
classifier. Accuracy, sensitivity and specificity metrics were involved in the evaluation 
process. SVM and C5.0 achieved highest accuracy rate of 81.3%, while Fuzzy e-means 
showed lowest accuracy rate of 37%. 
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This literature presents the most relevant and recent publications pertaining to the 
use of machine learning techniques for predicting breast cancer recurrence. The 
fundamental notion of this study comprises the recurrence status of breast cancer 
patient’s post-surgery using the classification algorithms. Following the outcomes of 
each machine learning method, the 10-fold cross-validation, hold out evaluation 
technique was employed. Furthermore, accuracy, sensitivity and specificity were also 
computed to compare the employed classification schemes. 
Table 2.2 Summary of review of prediction of cancer recurrence 
Authors Method Type of data 
Kim, et al., 2012 SVMs, ANNs, and the Cox 
regression 
Korean tertiary teaching 
hospital 
Salama, et al., 2012 DTs, MLP, SVM, NB, and 
KNN 
WBC, WDBC and WPBC 
Tomczak, 2013 NB, SVM, RF, and CART The Institute of Oncology, 
Ljubljana 
Chaurasia & Pal, 2014 DDTs, ANN, and LR The Institute of Oncology, 
Ljubljana 
Beheshti, et al., 2014 CAPSO, PSO, GSA, ICA 
with MLP 
Hepatitis, Heart Disease, 
Pima Indian Diabetes, 
Wisconsin Prognostic of 
Breast Cancer, Parkinson’s 
disease, Echocardiogram, 
Liver Disorders, Laryngeal 
1 and Acute Inflammations 
Ojha & Goel 2017 C5.0, KNN, NB, and SVM + 
K-Means, EM, PAM, and 
Fuzzy e-means 
 
WPBC dataset 
30 
 
Table 2.2 shows that most of these papers [28-33] used Wisconsin Prognostic Breast 
Cancer (WPBC) dataset for the prediction of breast cancer recurrence within five years 
period or longer. This current study utilised this dataset and presented better accuracy 
compared to [33] to decrease the mortality rate of patients and enhance  the survival 
rate. 
2.4 Cancer survivability prediction models  
Today, numerous predictive models have been developed to enhance health care and 
assist the physician to identify the cancer patient’s survival rate. Predicting breast cancer 
survivability is a daunting research challenge in general. Since the early dates of the 
related research, much progress has been made in numerous related fields.  For example, 
as a result of technological innovation in biomedical research, improved explanatory 
prognostic factors are being evaluated and documented due to affordable computer 
hardware and software technologies, high volume and better-quality data are being 
collected and stored automatically; and finally, because of advanced analytical methods, 
the processing of huge volumes of data is being done effectively and efficiently. As 
such, the primary goal of this study is to document a research project which fully exploits    
the advancements to produce models for the prediction of breast cancer survivability 
[11]. Towards this end, this current study, showcases various machine learning methods 
offer prediction of breast cancer survivability status.  
Chao et al. [34] suggested a predictive model to classify breast cancer survivability 
by presenting a treatment decision-making reference for 1,340 patients, who were  
diagnosed with breast cancer in Taiwan. They suggested a classification technique based 
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on support vector machine (SVM), C5.0 decision tree and logistic regression to detect 
breast cancer survival rates. They used 10-fold cross-validation method to compare the 
models. The evaluation of the classifiers was based on their accuracies. SVM displayed 
highest accuracy rate of 95.22% out of three classification techniques in survival 
approach.  
Wang et al. [43] presented synthetic minority oversampling technique (SMOTE) and 
particle swarm optimisation (PSO) method. Their approach is a combination algorithm 
with logistic regression, 1-Nearest Neighbour search, and decision tree (C5) method to 
improve 5-year survivability classification effectiveness of breast cancer patients of 
massive imbalanced data. A total of 973,125 patients and 118 variables were obtained 
from SEER breast cancer dataset, which was verified in 1973-2007. They separated the 
dataset into a training set and test set, a 10-fold cross-validation was taken to assess the 
performance of the classifiers. G-Mean and accuracy indicators were considered to 
measure the proposed method performance. The combination classifier of SMOTE + 
PSO + C5 showed the best accuracy among all other combination algorithms.  
García-Laencina et al. [35] evaluated a number of frameworks such as five-year 
survival prediction with and without imputation, K-Nearest Neighbours imputation, 
Expectation-Maximisation imputation, and Mode imputation to analyse  the incomplete 
or missing data. In this study, 399 breast cancer cases and 16 variables for each patient 
were obtained from the Portuguese Institute of Oncology of Porto (IPO). A predictive 
model for breast cancer survivability was constructed based on Support Vector 
Machines (SVM), Classification Trees, K-Nearest Neighbours (KNN), and Logistic 
Regression. Nested ten-fold cross-validation approach was performed in this 
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experiment, KNN algorithm showed highest accuracy rate of 81.73% in complex 
framework among all other methods.  
Thongkam et al. [36] applied a hybrid method to enhance breast cancer survivability 
prediction in Thailand by generating quality data sets. They solved the outlier and 
skewed data difficulties by utilising C-Support Vector Classification (CSVC) to exclude 
outlier cases and over-sampling with replacement to increase the number of cases in a 
minority class. Accuracy, sensitivity, and specificity, ROC, and F-measure were used to 
measure the effectiveness and capability of the suggested method. The 10-fold cross-
validation technique was used to decrease the variance and bias of the predictive model. 
SVM, C4.5, AdaBoost, and Bagging were utilised to evaluate the hybrid method. The 
best performance was achieved by SVM based on measurement methods such as 
accuracy, sensitivity, and specificity.  
Delen et al. [11] introduced a multi-layer perceptron (MLP) with back-propagation 
as an artificial neural network technique and decision trees (C4.5) with logistic 
regression to develop breast cancer survivability prediction. A total of 433,272 patients 
and 72 variables was obtained from SEER dataset for the years 1973-2000. The 10-fold 
cross-validation was considered to evaluate the performance of the classifier. Decision 
tree (C4.5) showed highest accuracy rate with 93.6% and logistic regression results the 
lowest accuracy rate with 89.2%.  
Bellaachia and Guven [37] utilised C4.5 decision tree algorithms, the back-
propagated neural network, and Naïve Bayes algorithm to find the most predictive 
survivability model of breast cancer patients. A total of 482,052 cases from SEER 
dataset for years (1973-2002) was considered. Survival Time Recode (STR), Vital 
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Status Recode (VSR), and Cause of Death (COD) fields were included. A set of tools 
was developed to obtain and clean up the SEER raw data. In their experiment, the Weka 
toolkit was employed with all data mining techniques and a C4.5 decision tree algorithm 
showed highest accuracy rate of 68.7%. 
Aljawad, et al. [38] applied Support vector machine (SVM) and Bayesian network 
(BN) models to predict the survivability status of breast cancer patients who had breast 
cancer surgery treatment. They compared the performance of SVM and BN on 
Haberman’s survival dataset. SMOTE technique was used before running the 
classification procedure to solve the imbalance data problems.  Weka software package 
was utilised to run these methods. Greedy approach was applied to optimize the 
parameters of the classifiers and raise the accuracy. Ten-fold cross validation technique 
was used in this experiment to assess the model. For evaluating the effectiveness of 
SVM and BN, many performance metrics were applied such as confusion metrics, 
Receiver Operator Characteristic (ROC) curves, recall, and precision. Support vector 
machine showed a higher accuracy rate of 74.44%, while a poor accuracy rate of 67.56% 
was presented by Bayesian Network. 
Predicting of breast cancer survivability is a daunting challenge for researchers and 
development of prediction models for breast cancer survivability post-surgery treatment 
is a significant undertaking. The ability to predict accurately and reliably the risk of 
cancer in average and high-risk individuals is important in preventing the occurrence of 
cancer and to ultimately advance clinical practice in the timely detection of cancer. This 
is very significant in saving lives and in the reduction of cancer-related healthcare costs.  
Table 2.3 shows that none of these papers [11, 34-37, 43] discussed the issue of 
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predicting the survivability of breast cancer patients’ post-surgical treatment. This 
current  research contributes to decision making following surgery treatment and 
performs with  greater  accuracy compared to [38]. 
Table 2.3 Summary of cancer survival prediction post-surgical treatment 
Authors Method Type of data 
Chao, et al., 2014 
Support vector machine, 
logistic regression, and a C5.0 
decision tree 
Central Taiwan 
diseases database 
Wang et al., 2006 
Synthetic minority 
oversampling technique 
(SMOTE) and particle swarm 
optimisation (PSO) 
SEER breast cancer 
dataset 
García-Laencina et al., 2015 
Mimp, EMimp and KNNimp + 
KNNclas, CTclas, Logistic 
LRclas and SVMclas 
 
 
Breast cancer 
dataset from 
Portuguese Institute 
of Oncology of 
Porto 
Thongkam et al., 2006 SVM, C4.5, AdaBoost, and 
Bagging 
Srinagarind 
Hospital in 
Thailand 
Delen et al., 2005 
Artificial Neural Networks and 
Decision trees 
 
SEER dataset 
Bellaachia & Guven, 2006 C4.5, Neural Network, and 
Naïve Bayes SEER dataset 
Aljawad et al., .2017 SVM and BN Haberman’s 
survival dataset 
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2.5 Chapter Summary 
This chapter, provided explanations, comparisons and assessments of the performance of 
various machine learning methods that were applied to cancer prediction and prognosis 
models. In particular, some trends were identified regarding the types of machine learning 
methods and training data being integrated, the kinds of endpoint predictions made, the 
types of cancers studied and the general effectiveness of these models in the prediction of 
cancer susceptibility or outcomes. Although ANNs continue to be dominant, it is obvious 
that an increasing number of alternate machine learning strategies is being used and 
applied to several types of cancers for the prediction of no less than three dissimilar kinds 
of outcomes. It is also evident that machine-learning methods in general enhance the 
effectiveness or predictive accuracy of most prognoses, particularly in comparison with 
conventional statistical or expert-based systems. Given that the majority of studies are in 
general well-constructed and reasonably well validated, there is still an urgent need to pay 
greater attention to experimental design and implementation particularly to the quantity 
and quality of biological data. Better experimental design as well as enhanced biological 
validation would improve the overall quality, generality and reproducibility of many 
machine-based classifiers. It is believed that should the quality of studies continue to 
improve, there is the likelihood that the use of machine learning classifier will be the 
standard most clinical and hospital settings for different prediction models for cancer. 
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Chapter 3: BREAST CANCER RISK ASSESSMENT 
This chapter discusses a model that accurately assesses the risk of breast cancer. An 
ensemble classifier model on microarray breast cancer gene expression datasets with 
CFS forward search is proposed. The proposed ensemble classifier is mainly to 
predict the riskiest genes to help physicians to identify breast cancer at the early 
stages.  
3.1 Background 
Breast cancer continues to be  the most deadly cancer affecting  women, despite the 
help of various awareness programs along with high-end research [44]. Researchers 
[45] have reported that the occurrence of breast cancer has increased dramatically. 
Approximately 2,088,849 new cases of breast cancer  were  diagnosed in 2018 alone 
which represents 11.6% of all cancers among women [46]. Annually, a little more 
than 1.1 million new breast cancer cases are diagnosed across the developed and 
developing countries. Among them, only 741,068 of them have survived. The 
mortality rate due to breast cancer among females in the decade is about 20%, with 
those in middle age, from 35 to 55 years being most vulnerable. When taken in 
conjunction with cardiovascular deaths, there was an increasing numbers of deaths 
due to breast cancer in all age groups while lung cancer taken in conjunction with 
breast cancer caused an increase in deaths among women, especially in the 60-85 
years age group [47].  
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Early detection of breast cancer will allow for more effective and significant 
treatment. Patients, researchers, and doctors involved in breast cancer prevention may 
use many risk assessments models to determine the risk of developing breast cancer 
in individuals. In order to increase the survival rate among women with high risk of 
breast cancer, many management strategies have been used to assess the risk of breast 
cancer as well as reduce the costs and complexities in low-risk women. The purpose 
of breast cancer risk assessment is to personalize management strategies over various 
age groups of adult females that carry a high percentage of risk. Management 
strategies placed by families with a readable description of BRCA1 and BRCA2 
mutations.BRCA1 or BRCA2 mutation in females carry a lifetime risk of breast 
cancer between 50% and 80% and ovarian cancer has lifetime risk between 10% and 
40% [48]. To lower the likelihood of breast cancer by at least 50% a prophylactic 
oophorectomy is used, which is referred to after childbirth and for every mutation 
carrier [49-51]. 
The main aim of machine learning models is to determine the effective variables 
and  their relationships [52]. These models can be used for prediction, estimation, and 
also for defining a process to design a good model that can be learned through 
experience  to improve its performance [6].  
Identification of suitable and informative subsets of features from microarray 
breast cancer datasets is based on certain criteria, for example, information gain and 
Gini index. There are several feature selection algorithms used nowadays in data 
mining techniques, for example, machine learning. A form of the selection of genes 
involves the selection of the most informative genes from microarray gene expression 
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data [53]. Usually, the gene expression data have a very high number of attributes (or 
genes features) but a relatively small number of observations. This problem poses a 
risk for the existing classification algorithms deployed for gene expression data.  
Furthermore, the microarray dataset, in the case of breast cancer data, has a high 
number of redundant gene attributes, among which some are irrelevant, while others 
can induce noise. These conditions lead to higher misclassification errors and lower 
model effectiveness [22].  
This chapter proposes an ensemble classifier that combines Deep Neural Network 
(DNN), Support Vector Machine (SVM), and Random Forest (RF) with five feature 
selection methods: Correlation-based Feature Selection with Forward Search 
(CFS_FWD), Fast Correlation-based Filter (FCBS), Random Forest (RF), Chi2 
discretization algorithm, and Relief for microarray gene expression breast cancer 
datasets to assist physicians to determine which genes are more highly and 
significantly related to breast cancer.  Adopting an ensemble algorithm with suitable 
selected genes, may help in the early identification of vulnerable breast cancer 
patients for whom suitable preventive treatments can be offered. Increasingly, 
ensemble methodology as an efficient method has been used for the combination of 
multi-learning algorithms to enhance the whole prediction accuracy. The 
contributions of the work described in this chapter are as follows: 
 The proposal of an ensemble classifier to assess breast cancer risks based on 
the most informative genes related to breast cancer. 
 The prediction of the most informative genes, which may be related and 
cause breast cancer at the early stages.  
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 The application of an evaluation method using the ensemble classifier 
showed higher accuracy compared to existing works [27]. 
3.2 Problem Overview  
Breast cancer classification is a core area of breast cancer treatment. Microarray 
analysis provides assessable information about disease diagnosis and perception of 
the basic structure of cell biology. The data-centric approach has been developed in 
previous years and integrated in the area of analyzing gene expression data, which is 
targeted at matching microarray analysis with information and knowledge from 
various accessible sources. High-throughput technologies such as Oligonucleotide 
chips and microarray can obtain gene expression data at various developing phases 
or in several tissues. Many machine-learning models can be used to predict the risk 
based on gene expression data. When analyzing the gene expression data, the key 
concern to observe is how to select the best informative set of genes. The microarray 
gene expression data possess unique characteristics, which are very different from 
traditional classification datasets. These gene datasets have very high dimensions 
(thousands of genes), very small number of observations (less than hundreds), and 
very high noise and irrelevance (among the genes). This kind of data is organized in 
a matrix represented by n rows and m columns. Genes are represented by n, while m 
represents the samples such as developing phases, different types of tissues or 
treatments. Various straightforward studies can be carried out such as comparing the 
genes (n) or samples (m). If two genes or samples are matched, then it can be 
hypothesized that those genes are functionally associated. Due to the complexity of 
the gene expression data, the expert cannot calculate or compute and evaluate the n 
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× m matrix manually. Therefore, machine learning approaches have been applied to 
classify gene expression data [54-59]. 
In the microarray breast cancer gene expression data, the number of training 
observations is smaller compared to the number of attributes. This problem leads to 
higher chances of over-fitting. Subsequently, caution is warranted when the current 
classifiers are used. Furthermore, the microarray data have higher noise and 
redundancy, which can affect the classification accuracy. The current classifiers are 
also not capable of handling high dimensional datasets. This problem warrants a 
feature selection algorithm to select a subset of suitable genes. Therefore, decreasing 
the gene attributes necessitates prior training using any classifier to understand the 
nuances of gene expression data.  
There is little research in the area of predicting the risk assessment of breast 
cancer. An individual classifier is proposed in [19], such as KNN, DT, SVM and NB, 
but this work focuses on identifying suitable patterns which could help classify 
tumours and various disease states, in addition to discovering  new disease forms. 
However, the drawback in such a study is that it poses a challenge of a low number 
of observations. The poor performance problem of classifiers without using feature 
selection algorithm is discussed in [20], but this review study requires certain features 
like filtering criteria, which can help in identifying suitable informative genes. SVM 
is proposed in [21]. This research focuses on feature selection methods based on SVM 
and they identified key features. However, this study has been limited to SVMs only. 
Four popular genes selection ranking methods are employed, namely, CC, CO, EU, 
and SN in [22]. In this study, SVMs and C4.5 were implemented. The drawback in 
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this research is that the results are based on 20 genes only. Radial Basis Function 
(RBF) Network classifier is proposed in [23] to differentiate the cancerous and 
noncancerous cells. Due to the limitations of this study, it has not been possible to 
deal with noisy data and multi-class gene expression datasets.   
A new feature selection method based on maximum correlation and minimum 
redundancy (MCMR) is applied in [25], but this work focuses on weighting the genes. 
This study differs from the current work, as it uses two iterations only based on 10-
fold cross-validation technique, while the current work uses 10 iterations. The issue 
of  the  instability in conventional independent component analysis (ICA) methods 
was resolved in [26] by using selective independent component analysis (SICA) to 
identify the best informative genes from microarray data. In this study, modified 
SVM classifier is used to produce the highest accuracy. However, this work produced 
less accuracy compared to this current study.  
Identifying suitable genes in lower dimensional spaces is discussed in [27].  SVM 
along with convex and piecewise linear (CPL) are considered as classifiers, this work 
is similar to the current study but shows low accuracy. It is important to build an 
ensemble classifier to improve the accuracy. The objective of the current study is to 
evaluate the performance of the current study’s ensemble classifier approach to 
determine which subset of genes is more highly and significantly related to breast 
cancer based on higher accuracy. 
3.3   Risk Assessment Prediction Model 
The present study analyzed five feature selection algorithms, namely CFS FWD, 
FCBS, RF, Chi2, and Relief. Then the reduced features were used with the ensemble 
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classifier of this current study, which was formed using DNN, SVM, and RF 
classifiers, to train and predict the relapse of the breast cancer data. During the feature 
selection, the following steps were performed to identify the most informative genes: 
 calculation of gene expression values in terms of the average and standard 
deviation (SD) for each of the n genes. 
 estimation of the absolute difference between the averages of gene 
expression values. 
 ranking of the most informative genes accordingly. 
 
Figure 3.1 Breast cancer risk assessment prediction model 
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Figure 3.1 demonstrates the study model; first, a feature selection is performed to 
reduce the dimensionality of the gene data. The ensemble classifier method of this 
study comprises three classifiers, namely DNN, SVM, and RF. These classifiers are 
used to train the datasets separately and then the results are combined as described 
below. The ensemble model was then compared with the existing classifiers [19]. The 
proposed ensemble method has shown higher test accuracy with a higher number of 
filtered genes. 
3.3.1  Feature selection 
Feature selection algorithms are primarily used to estimate the importance of each 
feature based on certain information criteria. The most desired features which provide 
higher variance during the building of classifiers are selected.  Such selection reduces 
the cost of computation. The building of a model generally requires fewer number of 
features. These features tend to be more robust with higher accuracy for feature 
selection by removing noise and redundant attributes. In feature selection, only the 
most significant features are selected without the need to generate new features.  
However, new features can be selected by using combinations of the existing features.  
There are three methods of feature selection: filter, wrapper, and embedded.  In the 
study model, Correlation-based feature selection in microarray datasets was used.  
3.3.1.1 Correlation-based feature selection 
As a filter algorithm, CFS ranks the subsets of features by using the evaluation 
function of a correlation-based heuristic [60, 61]. The bias of such evaluation function 
leans towards the subsets with features. These features correlate highly with the class, 
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but they do not correlate with other features. It is necessary to ignore irrelevant 
features, as they tend to correlate lowly with the class. It is also necessary to screen 
out redundant features as they may correlate with only one or a few of the other 
features. Generally, a feature can be accepted depending on how well it can predict 
the classes in spaces when other features have not predicted. CFS’r feature subset 
evaluation function is as follows:  
𝐶𝐹𝑆𝑟 =
ℎ𝑚௙௖തതതതത
ඥℎ + ℎ(ℎ − 1)𝑚௖௖തതതതത
                                                                                (3.1) 
where: 𝐶𝐹𝑆𝑟 is the feature subset’s heuristic “merit” and r contain h features, with   
  𝑚௙௖തതതതത  as the correlation between the mean feature and class (f ∊ r), and 𝑚௙௖ as the 
inter-correlation between the average feature and another feature. Equation (3.1) 
forms the core of CFS and ranks the feature subsets among those subsets in the search 
space. 
3.3.2 Ensemble Classifier  
Classification is well researched and used widely in machine learning, artificial 
intelligence, and statistics. Many classifiers have been proposed in the literature, for 
example, logistic regression, decision trees, linear discriminant analysis, and 
Bayesian. These classifiers have been assessed in cancer classification for the 
expression data of genes. Ensemble classifier is a combination of classifiers, which 
merge their decisions to generate a single combined output. Many scholars have 
recommended combining classifiers as a technique to enhance the performance of an 
individual classifier [62-66]. This technique has shown proficiency in supplying 
better consequences than employing the single classifier to the similar problem [65]. 
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In this chapter, an ensemble classifier is used, which comprises Deep Neural Network 
Classifier (DNN), Support vector machine (SVM), and Random Forests Algorithm 
(RF) models.  
3.3.2.1 Deep Neural Network Classifier (DNN) 
DNN is a type of ANN following the feed-forward method (with back-propagation) 
and has multiple hidden layers between the neurons for input and output [67]. The 
hidden layers h can be activated using logistic (or sigmoid) derivative functions to 
assign all the information from lower layers 𝑛௛ to a scalar state of layer  𝑚௞ , as in 
the following [67]:   
𝑚௛ = 𝑙𝑜𝑔𝑖𝑠𝑡𝑖𝑐(𝑛௛) =
1
1 + 𝑒ି௡௛
 , 𝑛 = 𝑐௛ + ෍ 𝑚௞𝑡௞௛
௞
                          (3.2)  
where: unit h has 𝑐௛ as the bias, index k is over the units in the layer below, and   
weight  𝑡௞௛  connects to unit h and unit k from the layer below.   
3.3.2.2 Support vector Machine (SVM) 
Support Vector Machine (SVM) [68] is a widely-used classification method known 
for its reliability and robustness. It is primarily utilised for both classification and 
regression. The linear SVM uses a hyperplane to classify the data and them 
transforms the input data into a higher dimensional space using kernel functions, such 
as radial basis function. Then it finds a high margin separating hyperplane in the high 
dimensional space that best separates the data points. It uses a quadratic Optimization 
to find the best separating plane. Once the SVM is trained with the training data, it 
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uses a small subset of the data called support vectors, to model the data. Then the 
trained SVM can be used with the test data for classification. 
Mathematically, let the training data contain  𝑛  datum (𝑎ଵ, 𝑏ଵ), (𝑎௡, 𝑏௡), 𝑎 ∈ 𝑋௡ 
and𝑏 ∈ {1, −1}. To let SVM carry out a good generalization ability, the classes have 
to be splitting and SVMs have to obtain the best splitting hyperplane. All the splitting 
hyperplanes are moulded with 
𝐷(𝑎) = (𝑣 ∗  𝑎) + 𝑣଴                                                                            (3.3) 
                                                                           
In addition, provide the difference for b = 1 and −1.  
        [𝑏௜(𝑣 ∗ 𝑎௜)+𝑣଴]  1, i = 1,..., n.                                                                 (3.4) 
The support vectors are represented by providing case of equality, while the 
classification of SVMs is employed by utilizing these support vectors. Margins of 
hyperplanes follow the obeying difference.        
𝑏𝑘 ×  𝐷(𝑎𝑘)
||𝑣||
  𝛤,   𝑘 = 1, . . . , 𝑛.                                                                         (3.5) 
To increase the margin (Γ), the norm of v is reduced. To decrease the quantum of 
results for norm of v, the obeying equation is clarified.  
          𝛤 × ||𝑣|| = 1.                                                                                          (3.6) 
Then, equation (3.7) is decreased subject to restriction (42).  
ଵ
ଶ
 ||𝑣||ଶ                                                                                                                        (3.7)                                         
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The non-divisible data are studied, and equations (3.4) and (3.7) add slack variables 
ξi.  Formulas (3.8) and (3.9) are applied rather than formulas (3.4) and (3.7). 
           [𝑏௜(𝑣𝑎௜)+𝑣଴]  1- ξi.                                                                              (3.8) 
              𝐶 = ෍  𝜉𝑖 + ଵ
ଶ
  
௡
௜ୀଵ
||𝑣||ଶ.                                                                    (3.9) 
While, SVMs classify the data linearly, SVMs do not perform the classification 
nonlinearly. Therefore, kernel methods are improved, to overcome this drawback on 
SVMs. Nonlinear t dataset is transformed into high dimensional linear data through 
kernels.  RBF kernels are used by SVM. RBF kernels obey RBF kernels:                      
         K (a, a′) = exp
 
(-∥a−a′∥2 / σ2)                                                               (3.10) 
Positive real number is represented by σ. 
3.3.2.3 Random Forests Algorithm (RF) 
The random forest classifier is a mixture of tree classifiers where a random vector 
generates each classifier by sampling individually from the input vector. Also, every 
tree creates a unit poll for the best common class for the classification of the input 
vector [69]. In this chapter, the random forest technique either randomly selects the 
attributes or grouping of attributes at every node to expand a tree. We have used 1000 
tree in this technique to represent the RF classifier. Bagging technique is used to 
create a training dataset randomly by replacing N example. N represents the original 
training set [70] Size, is applied to  every attribute or the combination of certain 
attributes.  
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The best common voted class is taken through classification of the examples [69]. 
To design the decision tree a feature selection evaluation and a pruning technique are 
essential. Number of feature selection is used to train decision tree and the best 
methods allocate a quality evaluation to the feature. The most popular feature 
selection algorithms in decision tree techniques are the Information Gain Ratio 
criterion [71] and the Gini Index [72]. Gini Index method is used as a feature selection 
technique by random forest classifier to assess the defilement of any feature with 
respect to the classes. The Gini index algorithm can be formulated as follows:  
             ∑ ∑ (𝑓(𝐶௫ ௫௬ , 𝑇)  𝑇)൫𝑓൫𝐶௬  ,𝑇൯  𝑇൯                                                (3.11) 
Where:  
T is a training set, while C represents a class. The probability for selected instance 
belongs to class Cx represented by (f (Ci,T)/|T).  
New training data extend to the maximum depth of tree by using a combination 
of attributes. The main advantage of the random forest technique is that the fully 
developed tree is not reduced [71]. Many researchers have proposed that using 
pruning technique rather than feature selection measure influences the performance 
of classifiers. Breiman [69], Mingers [73], Pal and Mather [74] proposed that the 
generalization error at all times has been converged despite the pruning of the tree 
process not being included while the number of trees is increased. Also, the over 
fitting process is not an issue due to Strong Law of Huge Numbers [75]. Sum of 
attributes utilised at every node to create a tree and a sum of trees to be expanded 
represent two user-defined parameters needed to produce a random forest method. 
Just chosen attributes at each node are examined for the best part. Therefore, the 
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random forest t contains N trees. N represents the number of trees to be produced 
which is determined by the user. The selected dataset is forwarded to the N trees 
respectively for classification task. For this purpose, the random forest selects a class, 
which is the most out of N polls.  
3.4   Performance Evaluation  
In this section, we state some important subsections such as experimental setup steps 
and evaluating the performance of the framework by comparing the performance 
metrics with the existing work to achieve best accuracy rate.  
3.4.1 Experimental Setup 
To evaluate the feature selection performance, holdout technique was applied 
(randomly selecting 80% training set and 20% test set in each iteration and repeating 
it for 20 iterations) to evaluate the performance of the classifiers. For each training 
data (in each iteration), DNN, SVM, and RF were run individually. Training set was 
used to estimate function estimator and this estimator was requested to predict 
accurately the risk of breast cancer by finding the most informative set of genes for 
testing data.  Test set was set to evaluate the model based on accumulated errors. This 
technique is preferable because of the reduced computing time.  
The evaluation criteria depend on the division data between training and test set. 
In this experiment,  Biocomb and H20 packages in R [76, 77] for implementation 
were used. For DNN and SVM the default parameters were used. Figure 3.2 depicts 
5 hidden layers were used to represents DNN input and outputs layers. For tuning 
DNN parameter (with ’rectifier’ activation, and 20 ephos/iterations), 5-fold cross-
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validation was used, and 10-fold cross-validation for SVM parameter (lambda) tuning 
(radial basis function with kernel param 0.005 was used for SVM). Once all the 
classifiers were trained, then the test data (20%) were used to find all the performance 
measures of the classifiers, such as accuracy, precision, and recall. Each classifier 
(DNN, SVM, and RF) provided the probability of being a relapse as an output (0 
being non-relapse and 1 being relapse).  
 
Figure 3. 2 Deep neural network layers  
 
The average of the probabilities (outputs) obtained from each classifier was 
computed as the ensemble output. The average was used to predict whether it was a 
relapse or non-relapse (with <= 0.5 as non-relapse and > 0.5 as relapse). Using all the 
results from 20 iterations, the average and standard deviation of the accuracy, recall, 
and precision metrics were calculated. 
3.4.2.1 Microarray Data Source  
DNA microarray technology has been widely applied in cancer research to predict   
breast cancer. This technology is a huge platform efficiently utilised to analyze gene 
expression in a broad collection of experimental studies. Nevertheless, due to the 
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large number of attributes (genes) and the small number of samples (instances) in 
such kind of datasets, microarray data analysis tackles "p which is large and n which 
is small.  This pattern is also referred to as the imprecate of dimensionality. Therefore, 
a pre-processing step in the microarray data analysis is involved, which includes an 
appropriate features selection before the classification step [78]. Due to the 
application of microarray technology, gene-expression dataset analyses many of 
thousands of genes on two sample cells. Based on the source of the samples a crucial 
examination should be performed such as disorder progress, precise diagnosis, drug 
response and post-therapy prognosis [79].  
This  chapter has  analyzed the publicly  available microarray breast cancer gene 
expression dataset [49], consisting of 97 samples of microarray tests with 24,481 gene 
expression levels. The data were divided into two groups: 19 control samples and 78 
cancer samples. For the control samples, nine cases were related to relapse samples 
and 10 cases were related to non-relapse samples. Among the cancer samples, 37 
cases were related to relapse samples and 41 cases were related to non-relapse 
samples. The control samples were used in the test process while the cancer samples 
were for the training process. 
3.4.2.2 Performance Metrics  
In this section, several performance metrics such as accuracy, sensitivity, and 
specificity are employed to measure the performance of the risk assessment 
prediction model. These metrics are as follows: 
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3.4.1.1 Accuracy 
Accuracy is an explanation of systematic errors,  evaluating the level of proximity of 
measurement among the original and the obtained value [80]. 
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =
𝑇𝑃 + 𝑇𝑁
𝑇𝑃 + 𝑇𝑁 + 𝐹𝑃 + 𝐹𝑁
  100                                                         (3.12) 
3.4.1.2 Sensitivity 
Sensitivity is used to evaluate the percentage of positives which are accurately 
classified. In this chapter, the percentage of risk assessment is measured, and  
accurately identifies the most informative genes, sometimes called the true negative 
rate [80].  
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =
𝑇𝑃
𝐹𝑃 + 𝐹𝑁
   100                                                                           (3.13) 
 
3.4.1.3 Specificity  
Specificity is used to evaluate the percentage of negatives which are accurately 
classified. In this chapter, the percentage of risk assessment is measured, to accurately 
identify the most informative genes, sometimes called the true negative rate [80]. 
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 =
𝑇𝑁
𝑇𝑁 + 𝐹𝑃
    100                                                                          (3.14) 
Where: 𝑇𝑃 indicates the true positives (equivalent with hit), 𝑇𝑁 represents the true 
negatives (equivalent with correct rejection), 𝐹𝑃 indicates the false positives, and  
𝐹𝑁  denotes the false negatives (equivalent with miss). 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3.5 Results and Discussion 
In this chapter, the experiment we conducted had two parts: first, the performance 
accuracies of the individual classifiers, which were DNN, SVM, RF, and AdaBoost 
was validated without using feature selection algorithms.  
 
Figure 3.3 Prediction summaries without using feature selection methods 
Figure 3.2 shows the graph of prediction summaries without using the feature 
selection methods. Furthermore, the proposed methods of DNN, SVM, and RF were 
applied to the breast cancer microarray gene expression dataset and the RF classifier 
was tested and achieved an accuracy of 70.78%±10.86%. The lowest accuracy 
detected from SVM was 56.31% ± 05.68%. 
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Figure 3.4 Prediction summaries by using feature selection methods 
Figure 3.3 shows gene selection technique performance using five gene selection 
methods of CFS_FWD, FCBS, RF, Chi2, and Relief with individual classifiers of 
DNN, SVM, RF, and AdaBoost. RF classifiers presented the best accuracy rate of 
91.32% ± 06.29% with FCBS feature selection method. However, SVM classifiers 
with Relief feature selection method performed poorly with the lowest accuracy rate 
of 65% ± 09.31% for 140 genes. The drawbacks of SVM with Relief feature is that it 
does not take into account the correlation probably hidden between features during the 
feature selection process [81]. 
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Figure 3.5 Prediction summaries by using feature selection methods with new ensemble 
method 
Figure 3.4 illustrates the proposed method performance with all five features 
selection methods. This method obtained the best accuracy results of 93.95% ± 03.44% 
with CFS_FWD feature selector, although the number of genes used was higher 
compared to other feature selection methods. Relief feature selector produced 140 genes, 
but it revealed the lowest accuracy rate of 76.05% ± 05.12 % with the proposed method. 
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Figure 3.6 Most informative genes related to breast cancer 
Figure 3.5 presents the results of finding the most informative genes relating to 
breast cancer. The “AB020713” gene showed a higher impact on breast cancer. In the 
graph, only the 10 most significant genes are shown out of 171 genes selected, for 
brevity. 
3.6 Chapter Summary 
Breast cancer is currently the deadliest disorder among females worldwide. Its   
treatment can be more affected and significant if this disorder is detected early. 
Machine learning tools-based prediction has been widely applied to determine breast 
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cancer risk. Developing a reliable and accurate model for making decisions regarding 
breast cancer risk is important, as it can save lives if detected in early stages. It is 
vital to find the genes that have high impact on breast cancer. Microarray breast 
cancer gene expression data usually have a large number of genes in comparison with 
the number of samples. Obtaining genes that have high impact on breast cancer is an 
important task. Hence, this chapter addressed this issue using an ensemble classifier 
with different feature selection methods to predict a subset of significant genes in the 
breast cancer data. Among others, the CFS with forwarding search feature selector 
(CFS_FWD) on the microarray breast cancer dataset showed better prediction results. 
Further, it revealed that the “AB020713” gene has the highest impact on breast 
cancer. Moreover, the ensemble-based classification method showed higher 
classification accuracy (93.95%± 03.44%) using 171 most significant features 
extracted using CFS_FWD feature selector. 
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Chapter 4: BREAST CANCER RECURRENCE MODEL 
This chapter investigates a method that accurately evaluatese the probability of breast 
cancer recurrence among patients. In this chapter, Random Forest classifier is proposed 
with Wisconsin Prognosis Breast Cancer dataset obtained from UCI machine learning 
repository. The proposed model is to assist medical physicians to propose possible 
treatments for breast cancer patients and reduce the mortality rate.  
4.1 Background 
Breast cancer is the most common diagnosed cancer among females, and the leading 
cause of death globally [46] . Figure 4.1 depicts in 2014 it was fourth to be most common 
reason of cancer fatality in Australia, with 2,814 women succumbing to it. The number 
was predicted to rise to 3,087 women in 2017 [82]. The deaths related to this disorder 
are typically associated with metastasis, which means the transfer of cancer cells from 
one organ to other organs in the body apart from the breast [83], and relapse, which 
refers  the disease recurring after the therapy stage [84]. Similarly, breast cancer patients 
may challenge critical treatment associated difficulties, which increase their risk of 
fatality from reasons irrelevant to breast cancer itself  [85].  
The treatment of breast cancer recurrence can be either local, such as surgery and 
radiation, or systemic, involving chemotherapy, hormone therapy, and immunotherapy.  
Breast cancer may recur within five years post treatment, with regional recurrence and   
distant metastasis included in this time. However, the probability of recovery is low once 
the recurrence occurs [76]. Hence, in this scenario there is a need to develop an accurate  
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Figure 4. 1 Breast cancer statistics  
 
approach to predict the probability of breast cancer recurrence to assist medical 
physicians to propose possible treatments for breast cancer patients. 
Advanced methods in data mining have emerged recently, which showed better 
performance than statistical methods [77]. Classification is the most common and widely 
used task in machine learning.  It aims to predict the outcome in invisible data and depict 
the important data classes by extracting the models [86]. Researchers [87] have obtained 
the knowledge from data sets by applying a single classifier. The decision tree is very 
frequently used in medical analysis. Scholars [11] have utilised decision trees to derive 
knowledge from medical data.  
Prior datasets are used to obtain knowledge by developing a data-mining algorithm 
in the classification task. The trends of each class have information, which is provided 
by prior datasets to predict new samples. Nowadays, classification methods cover many 
applications including medicine [88]. Wisconsin Prognostic Breast Cancer (WPBC) 
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(WPBC) dataset [13] represents imbalanced data. The dataset is called imbalanced when 
the majority class exceeds the number of the minority class [89]. In classification tasks, 
many unpredicted mistakes and even significant outcomes are available in imbalanced 
data, because the classification algorithms are affected by the biased distribution of class 
samples, which are biased to the majority class. The imbalanced data classification 
problems are solved by utilizing a re-sampling technique in data level as well as by 
classifying the design of a high-level model in algorithm level. To add to the number  of 
the minority class and avoid the over-fitting drawback, synthetic minority over-sampling 
technique (SMOTE) is proposed by researchers [90] for data pre-processing. 
In this chapter, the performance of Random Forest (RF) and Deep Neural Network 
(DNN) technique based on Wisconsin Prognostic Breast Cancer (WPBC) dataset [13] is 
estimated. Implementing the Random Forest classifier is an effective way to balance the 
data and estimate the importance of features that are applied in the classification task 
[91], whereas, Deep Neural Network classifier is able to obtain and simplify the 
imbalanced data [92]. These powerful classifiers may decrease the chance of mortality 
through timely diagnosis and avoidance of breast cancer recurrence among patients. The 
contributions of this chapter are explained as below: 
 This study proposed a breast cancer recurrence prediction framework to 
evaluate the probability of breast cancer recurrence post-surgery treatment.  
 This study also predicted the outcome class label attribute such as (R, N). R 
refers to the recurrent status, while N indicates the non- recurrent status.  
 The proposed model in this study enhances the accuracy of the recurrence 
probability among breast cancer patients compared to the existing work [33]. 
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4.2 Problem Overview  
After surgery treatment, breast cancer patients frequently obtain adjuvant treatment for 
a five–year period, as a provision against recurrence. Nevertheless, a number of patients 
face healing disappointment noticeable by disorder recurrence, in the type of local  
recurrence or remote metastasis [93]. These recurring disorder lesions frequently happen 
within the stage of adjuvant treatment, and indicate that remaining cancer cells do not 
react to adjuvant treatment or have low reactions [93]. If relapse does not occur during 
the management of adjuvant treatment, the occurrences of relapse will be sporadic [93, 
94]. These sporadic occurrences are supposed to be due to cancer cells departing 
inertness over time. Whereas, late disorder relapse is a signal of some stages of reactions 
to the adjuvant treatment, Initial detection of breast cancer recurrence affects serious 
risk to the patients’ lives. This type of method employing disorder features takes place 
at the time of early diagnosis, which assists in determining disorder prognosis and 
making decisions.  
Predicting the recurrence probability of breast cancer is significant because it 
decreases the mortality rate of patients and enhances the survival rate. Predicting   breast 
cancer recurrence is one of the actual health problems. Breast cancer recurrence is a 
cancer that re-occurs after an unspecific time when the cancer cells might not have been 
identified. In recent times, data mining has become a vital and effective tool for mining 
hidden patterns and knowledge discovery with large datasets. 
A number of researchers have published in the field of predicting the probability of 
breast cancer recurrence. The performance of three individual classifiers such as SVMs, 
ANNs, and  Cox regression has been investigated in [28]. This study focusses on 
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predicting the recurrence of breast cancer within a five-year period post-surgery 
treatment with St. Gallen’s guidelines Nottingham Prognostic Index (NPI), and 
Adjuvant Online. The classifiers in this experiment show poor performance compared 
to the method proposed. In the current study, the performance of  DTs, MLP, SVM, NB, and 
KNN approaches has  been compared in [29]. This study concentrates on using 
Wisconsin Breast Cancer (WBC), Wisconsin Diagnosis Breast Cancer (WDBC) and 
Wisconsin Prognosis Breast Cancer (WPBC). SVM and DT show better performance 
compared to other classifiers. However, low accuracy has been produced in this 
experiment compared to our proposed method. In [30] a number of machine learning 
methods have been evaluated. The focus of this research is to predict breast cancer 
recurrence statutes within a 10-year period for patients who underwent surgical 
treatment, and they also identified the input symptoms related to breast cancer 
reappearance. The comparison shows that there is still a need for more accurate 
classifiers. The performance of DDTs, ANN, and LR classifiers has been assessed in 
[31] as well as the performance of Dyadic Decision Trees (DDTs), Artificial Neural 
Network (ANN), and Logistic Regression (LR) classifiers. This study focuses on 
predicting the recurrence outcome of breast cancer patients in a five-year period post- 
surgical treatment. Poor accuracy has been resulted in this experiment. Several hybrid 
genetic approaches have been compared in [32] with nine datasets from different 
disorders have been used. This research aims to enhance the accuracy of the classifiers 
to help doctors to predict the disorders at early stages. However, in this experiment low 
accuracy was produced compared to the proposed method advocated in this current 
study. 
63 
 
The study of Ojha and Goel [33] focuses on estimating the probability of breast 
cancer recurrence among patients within a five-year period. C5.0, KNN, NB, and SVM 
classifiers were applied to individuals. SVM and C5.0 achieved best accuracy rates, but 
still poor compared to the method proposed in the current study. The purpose of this 
work involves predicting the probability of breast cancer recurrence based on the 
outcome attribute within a five-year period or longer to help the physician to make a 
decision regarding breast cancer recurrence.   
4.3 Breast Cancer Recurrence Prediction Framework  
In this model, this study evaluates the recurrence outcome of breast cancer patients, who 
underwent surgical treatment. The researcher took the publicly available Wisconsin 
Prognostic Breast Cancer (WPBC) dataset [13], which contains 35 attributes and 198 
instances including 151 non-recur, and 47 recur cases. ID number attribute was applied 
to denote the number of the patient. Time attribute was ignored as in a class label 
because the aim of this study is to predict if breast cancer will recur or not. Outcome 
attribute was used as a class label and represented two predicting fields such as (R, N). 
R represents recurrent, while N denotes non-recurrent. A total of 30 attributes with 10 
real variables was calculated for eight cell nucleus such as radius, texture, perimeter, 
area, smoothness, compactness, concavity, and concave points, symmetry and fractal 
dimension. The rest of the two attributes represent tumour size and lymph node status. 
In the current study, four instances were removed as their lymph nodes were missing. 
Researcher [95] is required to obtain the classifier true error rate in the entire 
population but it is impossible to approach the whole population in the real world. 
However, to estimate the true error rate only a limited set of cases was obtainable. To 
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address this issue of limited data a naive approach was applied to train the data. A serious 
over fitting and optimistic error estimation would be returned while using this approach. 
In the breast cancer recurrence problem, several sampling strategies are used such as 
holdout technique to overcome the over fitting issue, which separates the dataset into 
training and test data. The training set is employed to build the model, whereas, the test 
set is used to evaluate the performance of the classifier. Holdout technique splits the 
dataset into the train and test sets, which represent many partitioning schemes such as 
50%–50%, 70%–30% or 80%–20%. In the framework proposed for the current study, 
the researcher applied 70% train data and 30% test data. 
 
 
Figure 4.2 Breast cancer recurrence prediction framework 
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Figure 4.1 describes the breast cancer prediction framework using the Wisconsin 
Prognostic Breast Cancer (WPBC), which is an imbalanced dataset, to balance this type 
of data set; Synthetic Minority Over-Sampling Technique (SMOTE) was employed for 
the training data set. A grid search was utilised for Random Forest classifier. Grid search 
in RF was used to identify the best number of trees. 
Each branch in Random Forest represents a single decision tree without paper 
cutting. Flow chart of the tree represents the completion of decision tree building. The 
node represents the test of the feature, and the branch denotes the feature output. The 
final tree node represents the class distribution. The root node is the highest point of the 
decision tree. The main issue of the decision tree method is how to choose the feature 
dividing the nodes of the tree to obtain the best feature selection. Decision tree begins 
from the root node, two sub trees are divided by each sub tree and start to produce extra 
root node, which creates left and right sub trees. Each sub tree recursion continues to 
create another sub tree until the leaf node is reached. Several decision tree creation 
methods are available such as CLS, ID3, CART, and other node dividing methods. 
The idea of building N decision tree is to obtain N training set. Each sampling 
method includes replacement and the non-replacement methods. In the non-replacement 
method, the first sample units are obtained from the whole design by including the 
related signs of the unit. The whole number of units is reduced when the sampling 
method is not iterated in the selection process. There is no possibility of the pumping 
repeating for each unit. The replacement sampling is the opposite of the non-
replacement one. When the sampling process is completed, the original dataset is 
generated by replacing the samples into the original dataset without any changes. Two 
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types of replacement sampling are available including the unweighted and the weighted 
sampling to evaluate the Random Forest classifier. 
 
 
4.4 Performance Evaluation 
In this section, we study the performance of the proposed approach. The experimental 
setup, the metrics, and the results of the experiments are presented. We choose the 
approach proposed in Ojha and Goel [33] as a benchmark because it is the latest work 
with good result and directly related to our work. 
4.4.1 .Experimental Setup 
Two experiments were performed: first, the existing work was validated, which was 
achieved by Ojha and Goel [33]. They assessed the performance of SVM and C5.0 by 
splitting the Wisconsin Prognostic Breast Cancer (WPBC) dataset [13] into 70% for the 
training set and 30% for the test set. Their experiment is described in the related work 
section. The current study authenticated the performance of SVM and C5.0 with the 
same classification technique by dividing the dataset into 70% train data and 30% test 
data. In this experiment, 20 iterations were applied to calculate the average and standard 
deviation of accuracy, precision, and recall metrics. R platform was employed to predict 
the probability of recurrence among breast cancer patients. Two packages were applied 
in this experiment. Package ‘Probsvm’ [96] for SVM, and Package ‘C50’ [71] for C5.0 
model were  used. Six parameters for SVM were employed such as fold, kernel, Kparam, 
Inum, type, and lambdas, while all default parameters for C5.0 were applied such as 
subset, bands, winnow, noGlobal Pruning, Confidence Factor (CF), min Cases, fuzzy 
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Threshold, sample, early Stopping, seed, and label. The accuracy, precision, and recall 
measures were used to assess the performance of the models. 
A total of 20 Iterations were applied to calculate the average and standard deviation 
by utilising grid search to optimise the parameters of SVM and C5.0 models. The values 
of the SVM parameters after optimisation are as follows: fold =10, kernel = radial, 
Kparam = 0.01, Inum = 30, type = ovo , and lambdas = 0.000976, 1, 1024,  while, the 
parameter  values for C5.0 after optimisation process are   as follows: subset = TRUE, 
bands = 0, winnow = FALSE, no-Global Pruning = FALSE, CF = 0.25, minCases = 2, 
fuzzy Threshold = FALSE, sample = 0, seed = sample.int (4096, size = 1) - 1L, early 
Stopping = TRUE, and   label = outcome. 
Second, in the study experiment the RF and DNN models were independently 
validated by splitting the data into two groups, for example, train data (70%) and test 
data (30%). To evaluate the performance of these models, several performance 
metrics were employed such as accuracy, precision, and recall. The study’s proposed 
method achieved higher accuracy compared to the existing work. 
4.4.2 Performance Metrics  
Several measures were used in this experiment such as accuracy, precision and recall. 
The internal and external factors affect random forests, invariably causing inequitable 
classification performance. Several types of metrics measure the classification 
performance such as the classification effect, OOB, and running efficiency. 
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Table 4.1 Confusion matrix of binary data 
Classification Actual positive Actual negative 
Positive classified TP FP 
Negative classified FN TN 
Table 4.1 illustrates the confusion matrix of binary data. TP denotes the number of 
positive class samples, while TN denotes the number of negative class samples. Both TP 
and TN are applied in the correct classification. FP indicates the number of positive class 
samples, whereas, FN indicates the number of negative class samples. FP and FN are 
employed in the incorrect classification. The following steps are followed to evaluate 
the classification effect on the random forest classifier: 
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =
𝑇𝑃 + 𝑇𝑁
𝑇𝑃 + 𝑇𝑁 + 𝐹𝑃 + 𝐹𝑁
                                                             (4.1) 
Step 4.1 explains the overall accuracy of the classification measured by accuracy 
metrics, and higher accuracy indicates the better classification performance. 
𝐺 − 𝑚𝑒𝑎𝑛 = ඨ
𝑇𝑃
𝑇𝑃 + 𝐹𝑁
 ×
𝑇𝑁
𝐹𝐵 + 𝑇𝑁
                                                        (4.2) 
Step 4.2 represents G-mean, which measures the overall accuracy of the 
classification, and higher accuracy indicates the better classification performance. 
𝐹 − 𝑣𝑎𝑙𝑢𝑒 =
(1 + 𝛽ଶ) × 𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 × 𝑟𝑒𝑐𝑎𝑙𝑙
𝛽ଶ × 𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 + 𝑟𝑒𝑐𝑎𝑙𝑙
     × 100%                     (4.3)  
F value in step 4.3 is a type of classification evaluation metrics, which describes 
the recall and precision. 
69 
 
4.5 Results and Discussion  
Table 4.2 Prediction summaries of SVM and C5.0 models 
Classifier Accuracy Precision Recall 
SVM 77.19%± 0.00% 77.19% ± 0.00% 100 % 
C5.0 74.74% ± 5.16% 83.41% ± 3.10% 84.09% ± 6.51% 
From the existing work experiment [33], Table 4.2 indicates  that SVM model shows 
highest accuracy rate  of 77.19% ± 0.00%, while C5.0 presents lower accuracy rate of  
74.74% ± 5.16%. C5.0 illustrates the best precision of 83.41% ± 3.10% compared to the 
lowest precision stated by SVM; 100% is the recall rate recorded by SVM, whereas, C5.0 
shows lower recall rate at 84.09% ± 6.51%.  
Table 4.3 Prediction summaries of SVM and C5.0 models after optimisation process 
Classifier Accuracy Precision Recall 
SVM 76.71% ± 1.26% 77.29% ± 2.12% 98.62% ± 2.53% 
C5.0 74.21% ± 6.42% 82.46% ± 4.70% 84.48% ± 7.19% 
Table 4.3 [33] presents the performance of the SVM and C5.0 models after 
optimising the classifier’s parameters. SVM shows highest accuracy rate (76.71% ± 
1.26%) while, C5.0 shows lowest accuracy rate (74.21% ± 6.42%).  C5.0 model achieves 
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the best precision rate (82.46% ± 4.70%) compared to the lower precision rate (77.29% 
± 2.12%) of SVM.  Best recall rate (98.62% ± 2.53%) is by SVM while C5.0 shows 
lower recall rate of 84.48% ± 7.19%. 
 
Figure 4.3 Prediction summaries of RF and DNN techniques 
In the experiment conducted in the current study, Figure 4.2 shows that the RF model 
shows the highest accuracy rate of 98.63% ± 2.56%. Although the DNN model shows 
lowest accuracy rate of 77.44% ± 1.22%, the precision rates of RF and DNN models are 
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98.81% ± 2.09%, 77.40% ± 1.0% respectively, while recall rate is 100%, 99.45% ± 
1.73% respectively. 
4.6 Chapter Summary  
Early detection of breast cancer is now considered a critical factor in the field of data 
mining. An accurate prediction of the probability of breast cancer recurrence plays a 
vital role in preventing breast cancer recurrence. In this chapter, Wisconsin Prognosis 
Breast Cancer data set was obtained from the UCI machine learning repository. To 
balance the data, a SMOTE technique was employed. The recurrence statutes are 
represented by R and N. The results of extensive prediction models for assessing the 
probability of recurrence status of breast cancer patients are listed in this study. Holdout 
technique was applied by splitting the dataset into 70% training set and 30% for test set. 
RF model showed better accuracy performance than DNN compared to the existing 
work. 
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Chapter 5: PREDICTING BREAST CANCER 
SURVIVABILITY 
This chapter reports a technique that precisely predicts survival status of breast cancer 
patients who underwent surgery treatment the past five years or longer. In this 
chapter, Deep Neural Network classifier model on Haberman’s Survival dataset from 
the University of Chicago's Billings between the years 1958 and 1970 is proposed. 
The proposed classifier is to increase the survival time and reduce the mortality rate 
of breast cancer patients. 
5.1. Background 
Breast cancer is the most prevalent cause of cancer deaths among women worldwide 
[97]. About quarter million females were estimated in 2017 to have breast cancer and 
40,610 breast cancer deaths are projected to occur in the United States. The survival rate 
within a five-year period among them is based on the race and year of diagnosis which 
was 90% [98]. Scientists have identified the factors that increase the probability of 
developing breast cancer. Age, family history, and genetic risk are attributes of these 
factors. Generally, two types of breast cancer treatment are available-a local and a 
systematic treatment. Surgery and radiation therapy are examples of local treatment and 
chemotherapy is considered as systematic treatment. To decrease the spread of breast 
cancer many treatment  methods are used, for example, chemotherapy, hormone therapy, 
or both at the same time to reduce distant metastases by 33.33% [99].  
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The major challenge in breast cancer treatment is predicting survivability of the 
patients after a specific treatment regime. Breast cancer survivability prediction can 
assist healthcare providers to make decisions about alternative treatments to improve the 
quality of life of the patients. It can also enable healthcare providers to develop 
customised treatments to increase the treatment efficiency [100]. This has motivated 
research in breast cancer survivability prediction [11, 34-38, 43].  
The focus of [34] was on predicting the survivability status by presenting a treatment 
decision-making reference on Taiwan patients, who had been diagnosed with breast 
cancer. This particular research differed from the current study which focuses on 
predicting the survivability status post-surgery treatment within a five-year period. The 
work in [43] was to improve the survivability classification of breast cancer patients of 
massive imbalanced data within a five-year period. This research is related to the current  
work, but its results appear poor. García-Laencina, et al. [35] evaluated a five-year 
survival prediction with and without imputation. The comparison in this research shows 
lower accuracy rate compared to the results of the current  work. Thongkam, et al. [36] 
utilised a hybrid technique to improve survivability prediction of breast cancer patients 
in Thailand by creating quality data sets. SVM achieved best performance and it is 
different from this present study as it presented lowest accuracy results. Delen, et al. 
[11] applied an ANN method and C4.5 with logistic regression to predict survivability 
status among breast cancer patients. C4.5 showed high accuracy in this work but 
compared to the results of this current study the accuracy produced was lower. 
Bellaachia and Guven [37] proposed a survivability prediction model for breast cancer 
patients by applying different algorithms such as C4.5 decision tree, the back-
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propagated neural network, and Naive Bayes.  However very low accuracy was 
achieved. Aljawad, et al. [38] applied Support vector machine (SVM) to estimate the 
survivability status of breast cancer patient’s post-surgery treatment and showed less 
accurate result compared to the results of this current study.    
Although many breast cancer survivability prediction techniques have been 
proposed in the literature, their accuracy remains low, thus rendering them unreliable to 
a certain degree. Hence, an accurate survival model is needed to predict accurately breast 
cancer survivability post-surgery treatment.  
The aim of this study is to predict the patient’s survival status post-surgery treatment.  
To address this issue, this researcher evaluated the performance of Deep Neural Network 
(DNN) and Random Forest (RF) classifier based on Haberman’s survival dataset.  DNN 
with multiple layers is able  to generalise and extract imbalanced data [92], while RF is 
used to balance error in imbalanced data and calculate the importance of attributes used 
in the classification process [91]. The contributions of this study can be summarized as 
follows: 
 A proposed deep learning-based survivability prediction approach 
 The development of a predictive survival system model     
 A proposed DNN method, which achieves higher classification accuracy in 
comparison with  the existing literature [38], which helps to save patient's 
lives. 
The rest of the chapter is organised as follows: first, the works related to survivability 
prediction of breast cancer dataset are presented, followed by a description of the 
methodological steps taken, and the algorithm applied to predict the survivability status 
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of breast cancer patient’s post-surgery treatment. Next, the framework of survivability 
prediction of breast cancer patients is illustrated followed by the report of   the 
performance analysis of survival evaluation method. Finally, the conclusion is drawn 
regarding the achieved results. 
5.2. Breast Cancer Survivability Framework 
After a patient has been diagnosed with breast cancer, doctors will decide which therapy 
has to be applied based on the disorder stage. The aim of breast cancer treatment of 
stages 1-3 is to eliminate the cancer cells and prevent the cancer from recurring. As for 
stage 4, the goals of the treatment include decreasing the pain, improving the quality of 
the patient’s life and survival.  
A number of therapies are available such as hormone therapy, targeted therapies, 
and emerging areas of treatment, chemotherapy, radiotherapy, and surgery. Surgery 
treatment removes lumpectomy or mastectomy, while radiotherapy treatment is required 
in some cases to reduce the chances of the tumor spreading or returning. The aim is to 
predict the patient's survival status among breast cancer patients who underwent surgical 
treatment the past five years or longer.  
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Figure 5.1 Breast cancer survivability framework 
Figure 5.1 demonstrates two parts of the proposed breast cancer survivability 
Framework. First part of the proposed framework uses the dataset. It is publicly 
available from UCI machine learning repository [14]. The University of Chicago’s 
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Billings Hospital has collected the data of surviving breast cancer patients who had 
experienced surgery treatment.  
Table 5.1 Analysis of Haberman’s survival dataset 
Statistical 
Measure 
Age of Patient 
 
Year of 
Operation 
Number of Positive 
Nodes Detected 
Mean 52.458 62.853 4.026 
Median 52 63 1 
Standard 
deviation 
10.803 3.249 7.19 
Maximum 83 69 52 
Minimum 30 58 0 
Table 5.1 analyses the Haberman’s survival imbalanced dataset [100] which is 
divided into two classes, majority, and minority. It consists of 306 samples with four 
numerical variables such as the age of a patient at the time of operation, ranging from 
30 to 83 years; a patient's year of operation (year-1900) ranging from 0 to 52. A total of 
225 samples out of 306 samples belonged to class 1, which represents the patients who 
survived five years or longer and 81 samples belonged to class 2, which denotes the 
patients who died within five years.  
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gure5.2 The corelation analysis between variables in Haberman’s survival dataset 
Figure 5.2 The correlation analysis between variables in Haberman’s survival dataset 
Figure 5.2 depicts the correlation analysis between variables in Haberman’s survival 
dataset, while the class variable is performed to detemine how these variables are 
connected. It is divided into two classes, majority, and minority. Majority class has a 
massive number of samples compared to the minority class. Imbalanced data are an 
interesting and challenging classification area to the researcher, due to many data mining 
tools used  to balance the data, while those tools are not employed for imbalanced data 
[101]. Higher accuracy results were obtained in the majority class, when using these 
tools compared to lower accuracy with the  minority  class [102]. Currently, the mortality 
rate has been reduced, and survival time increased by applying sophisticated cancer 
diagnosis and treatments. Therefore, survival of the number of patients is higher 
compared to non-surviving patients. The second part of the proposed framework is the 
classification task, which comprises many steps, and with the first step on how to 
evaluate the model, we individually validated the DNN and RF classifiers by dividing 
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into (80%) training set and (20%) testing set. Training set is used to estimate function 
estimator which is to predict the survivability outcome values for testing data. Test set 
is used to evaluate the model based on accumulated errors. This technique is preferable 
because it requires less computing time. The evaluation criteria depend on the division 
data between training and test sets. Researchers have solved the imbalanced data 
classification problems by re-sampling the data level and by utilising the classification 
of a designed sophisticated method in algorithm level. The second step is the Synthetic 
Minority Over-sampling Technique (SMOTE). Researchers [90] proposed a re-sampling 
method for data pre-processing known as SMOTE. It is employed to avoid the over-
fitting problem, which increases the samples number in minority class instead of 
replication. SMOTE [90] is an over-sampling technique carried out in feature space 
instead of data space. New synthetic instances are created in the original dataset by 
having, ore samples for the minority class, which leads to broader decision regions for 
the minority class, although the decision region of the minority class is more limited 
because of simple over-sampling with replacements. 
The number of Nearest Neighbours (k) and the over-sampling rate (percentage) 
parameters are specified to create new synthetic samples. Chawla, et al. [103] described 
the generating steps of the new synthetic samples for continuous features as follows: 
 Calculate the distance between feature vector and one of its k nearest neighbours 
in the minority class. 
 Multiply the distance in the previous step by random number located between 
0 and 1. 
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 Select the feature value of the initial feature vector from the previous step.  A 
new feature vector is generated by: 
        𝑠௡  = 𝑠௢ + 𝛿. (𝑠௢௜ − 𝑠௢)                                                                         (5.1) 
Where: 𝑠௡ denotes the sample of a new synthetic data.  In the minority class, 
 𝑠௢ represents a feature vector of a sample. 
The ith picked nearest neighbour of 𝑠௢ is 𝑠௢௜, the random number between zero and 
one is represented by δ. The three steps mentioned above are reiterated nine times. The 
new synthetic instance is generated each time; randomly, one of the five nearest 
neighbours us selected. 
In machine learning every algorithm possesses a set of hyper parameters, which 
needs optimisation to enhance prediction performance through a simple method known 
as grid search, which involves trying all possible parameter value combinations to 
determine the best parameter values. On the other hand, grid search technique is 
employed in the proposed framework of the present study to select the optimal number 
of epochs and nodes in the hidden layers.  
The structure of deep neural network is based on multi-layer artificial neural 
network. It uses forward search along with back-propagation technique, which includes 
one or more hidden sections between input  and output neurons [67]. The classification 
process is divided into training and testing phases. Deep learning classifier is used to 
train the variables in the training phase. Neural networks are represented as a self-
adaptive technique and data driven. Deep neural networks learn more complex models 
than shallow ones due to their deep architectures. We used the same equation in equation 
3.2.  
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An index over all classes represented by 𝑖: 
                 𝐶𝐹 = − ෍ 𝑝௛ 𝑙𝑜𝑔 
௜
𝑐௛                                                                  (5.2) 
The cost function is represented by 𝐶𝐹, where 𝑝 is the cross-entropy between the target 
probabilities and 𝑐 is the output of the softmax. 
∆𝑤௞௛(𝑞) = ∆𝑤௞௛(𝑞 − 1)−∈
డ஼ி
డ௪ೖ೓(௤)
                                                                        (5.3)   
To evaluate the proposed method on testing data, a 10-fold cross-validation 
technique is used to classify and improve the model performance. Kohavi [104] reported 
that the K-fold cross-validation is also known as rotation estimation. D dataset is 
randomly divided mutually into K folds D1, D2, 𝐷௞ of estimated same size. K times are 
tested and trained by the inducer, 𝐷ଵ, 𝐷௧ is trained by each time t ∈ {1, 2, k} and in 
addition, tested on 𝐷௧. The accuracy of an overall number of precise classifications is 
estimated by the cross-validation.  
Assume 𝐷(௜) represents the test set samples 𝑥௜ (𝑣௜ , 𝑦௜ ). Then, the accuracy of cross-
validation is estimated by: 
𝑎𝑐𝑐௖௩ =
1
𝑛
෍ 𝛿(𝐼
(௩೔ ,௬೔ )∈஽
൫𝐷൫𝐷(௜)  , 𝑣௜ ൯, 𝑦௜ ൯                                                   (5.4) 
The average of 10 iterations has been applied in the classification task. After getting the 
survivability prediction results the doctors will make appropriate decisions.   
5.3. Performance evaluation 
This section presents some important metrics that are used for evaluation of the model’s 
performance, and the steps of setting up the experiment process.  
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5.3.1 Evaluation Measures 
This study uses three metrics to evaluate the prediction performance of the model, 
specifically, accuracy, sensitivity, and specificity metrics, which are defined as follows: 
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =
𝑇𝑃 + 𝑇𝑁
𝑇𝑃 + 𝑇𝑁 + 𝐹𝑃 + 𝐹𝑁
                                                             (5.5) 
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =
𝑇𝑃
𝐹𝑃 + 𝐹𝑁
                                                                                 (5.6) 
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 =
𝑇𝑁
𝑇𝑁 + 𝐹𝑃
                                                                                 (5.7) 
𝐺 − 𝑚𝑒𝑎𝑛  = ඥ𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦  ×   𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦                                          (5.8) 
Where: 𝑇𝑃 indicates the true positives,  𝑇𝑁 represents the true negatives,  𝐹𝑃 indicates 
the false positives, and  𝐹𝑁. denotes the false negatives 
5.3.2 Experimental setup 
This section validates two experiments. Firstly, we validate  the existing work of 
Aljawad, et al. [38]. They compared the performance of Applied Support vector machine 
(SVM) and Bayesian network (BN) classifiers based on Haberman’s survival dataset. 
They solved the imbalanced dataset drawback by using SMOTE technique before 
implementing the classification task. Their model was evaluated by using 10-fold cross-
validation only. They optimised their classifiers parameters by applying greedy 
technique. A number of performance metrics was utilised for the evaluation of the model 
performance like confusion matrices, Receiver Operator Characteristic (ROC) curves, 
recall, and precision. Weka platform was applied for the prediction of the survival status 
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of breast cancer patients who underwent surgery treatment in the last five years or 
longer. 
Secondly, the entire work was conducted by using R to evaluate the proposed 
framework performance of this current study. Table 5.2 compares  the current study with 
existing studies [38], this experiment applied two classification evaluation systems such 
as 10-fold cross-validation and holdout technique (80% Training, 20% Test sets). 
5.4. Discussion of Experimental Results  
As Haberman’s survival dataset is imbalanced data, Synthetic Minority Oversampling 
Technique (SMOTE) filter was used to balance the dataset. The accuracy, precision, and 
recall metrics were employed to evaluate the performance of the classifiers.  
Table 5.2 Summary of existing work [38] on prediction models 
Method Accuracy Precision Recall 
BN 67,70% 67,70% 67,80% 
SVM 64,40% 64,60% 67,80% 
Table 5.2 shows BN classifier provides best performance rate such as accuracy 
(67.70\%), precision (67.70%) and recall (67.80%), while, SVM produced lower 
performance rates such as accuracy (64.40%), precision (64.60%) and recall (67.80%). 
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Figure 5.3 Prediction summaries of DNN and RF using 80% training and 20% test sets 
Figure 5.3 shows that the proposed method in this current study achieved higher 
accuracy compared to the existing works [38]. From the results, it can be seen that the 
DNN Classifier presents the highest accuracy rate of 83.18%, while the lowest accuracy 
rate of 79.97% is by RF classifier. A rate of 89.34% is the precision rate of the RF model, 
suggesting that RF has good ability to find positive class among positive samples. DNN 
presents the lowest precision rate of 85.54%, which indicates a large number of False 
Positives. DNN shows best recall rate of 97.19%, which suggests that DNN model is 
more reliable to obtain positive class. A low recall rate indicates many False Negatives. 
 
85 
 
Figure 5.4 Prediction summaries of DNN and RF using 10-fold cross-validation 
Figure 5.4 demonstrates that DNN classifier provides the highest accuracy rate of 
83% versus 76.58% accuracy rate by RF model. A precision rate of 90.17% is achieved 
by RF approach, while, DNN model shows lower precision rate of 83.32%.  DNN 
classifier produces higher recall rate of 98.71%, while the lowest recall rate of 88.11% 
is from the RF model. 
5.5. Chapter Summary 
The major challenge for breast cancer patients, who underwent surgery treatment, is how 
to estimate the survivability outcome within five years or longer. Predicting the 
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survivability statutes of breast cancer patients could assist physicians to make a decision 
about breast cancer treatments. The survival variable is represented by one and two 
numbers. In the current study, this experiment validated the existing work [38] by 
verifying their work using Weka platform. This was followed by the validation of the 
proposed survivability framework, which includes several sections such as Haberman's 
survival dataset from UCI machine learning repository, SMOTE technique used to 
balance the dataset, grid search method employed to optimise the classifier’s parameters, 
and DNN classifier, which was used to improve the classifier accuracy. Holdout 
technique (80% Training/20% Test sets) with 10 iterations was applied to measure the 
accuracy, precision and recall metrics of this framework. Overall, this framework by 
using DNN classifier achieved better performance than RF in both techniques compared 
to the existing work. 
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Chapter 6: CONCLUSIONS AND FUTURE WORK 
Breast cancer is a type of cancer with a high mortality rate among females and it is the 
most prevalent cause of cancer death among females worldwide. A number of challenges 
such as rise in life expectancy, increased urbanisation, and adoption of western lifestyles 
in developing countries have increased the risk of breast cancer incidence. Due to breast 
cancer being diagnosed at very late stages in middle-income countries, the majority of 
breast cancers in those countries cannot be eliminated even by using prevention 
strategies.  
Over the last few years, there have been remarkable advances in medical science 
including the introduction of novel treatment options that are accessible to cancer 
patients, new approaches to timely detection, new drugs or new drug indications, new 
surgical devices, new radiation treatment methods, and new technologies for the 
diagnosis and monitoring of patients. Scientists have used various approaches including 
screening in early stage, to detect a cancer prior to the emergence of the disease 
symptoms.  Furthermore, they have innovated novel techniques for the timely prediction 
of cancer treatment outcomes. 
Despite the fact that cancer can result in a positive outcome if detected early, the 
vast majority of patients are diagnosed with cancer very late. Furthermore, it is not 
uncommon for cancer to come back after years of treatment. Cancer recurs because tiny 
portions of cancer cells may remain undetected in the body after treatment. Therefore, 
the early diagnosis and prognosis of a cancer have become a necessity in cancer 
research. An interesting and challenging research is how to predict cancer occurrence 
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and recurrence risks as well as early prediction of cancer treatment outcomes. This line 
of research is active but remains unresolved. This is especially true for breast cancer 
research, which is the focus of this present research.  
Researchers may apply efficient machine learning tools to construct models and 
approaches that may help doctors in the process of investigation and therapy. However, 
in some cases, women develop breast cancer that becomes distantly metastasised, which 
is common in the late stages, and consequently, has a low survival rate. Survival rates 
for breast cancer differ significantly depending on the cancer type, stage, therapy, and 
geographical location of the patient. 
This thesis contains three sections. The first section concentrated on the risk 
assessment problem of breast cancer; the second section homed in on the recurrence 
issue, while the third section emphasises the survivability problem, and the many new 
investigation drawbacks and solutions that have been identified in this thesis. 
This study investigated the existing methods for risk assessment, recurrence, and 
survivability status prediction that have been unable to provide sufficiently accurate 
results. In most existing methods, a small number of genes was used in the risk 
assessment issue estimation. Moreover, low accuracy has been shown in case of breast 
cancer recurrence and survivability outcome prediction for patients five years or longer 
post-surgical treatment.   
This thesis has addressed the above problems and applied an ensemble classifier to 
accurately predict the most informative genes, which may be related to breast cancer 
disorder, and proposed algorithms for patients who had undergone surgical treatment 
five years ago or longer by estimating the probability of breast cancer recurrence 
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outcomes, and precisely predict survival status. Additionally, this chapter summarises 
the main contributions and achievements and provides relevant recommendations for 
future work. 
6.1  Contributions and Achievements 
Breast cancer remains a substantial scientific, clinical, and societal challenge and there 
is active research worldwide to address this problem. The overall aims of this thesis are 
to scrutinise existing risk assessment, survivability, and recurrence approaches for breast 
cancer. 
The study offers several contributions to the literature on breast cancer prediction at 
early stages. It has introduced an accurate prediction model to predict risk assessment, 
recurrence, and survivability outcomes. In more detail: 
 the thesis made a comprehensive survey of breast cancer prediction issues 
such as risk assessment, recurrence, and survivability, which contain a 
number of outdated statistical models, latest statistical methods, and earlier 
experiments, which have applied several machine-learning approaches with 
different datasets. 
 this research compares many different machine-learning models with each 
other until the best algorithm performance is attained. The comparisons 
between approaches are based on the use of predicting outcomes for breast 
cancer patients.  
 an ensemble classifier on microarray breast cancer gene expression datasets 
with most popular feature selection algorithms is proposed to identify 
accurately the risk of breast cancer based on the most informative genes with 
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respect to the chances of developing a cancer in the near future. This 
approach has not previously been applied in breast cancer applications. 
 decision tree model is proposed with Wisconsin prognosis breast cancer 
dataset to predict accurately the probability of cancer recurrence for patients 
after surgery treatment within a five-year period or longer. This proposed 
method shows best accuracy performance compared to the existing work.  
 neural network and decision tree models are included in the comparisons: 
These models have been proposed in previous research, but poor accuracy 
results have been stated in the literature. This current study used Haberman’s 
Survival dataset to estimate survival outcome of breast cancer patient’s post-
surgery treatment.  
6.2 Review of Major Findings 
Several methodologies that include modelling, formal (i.e., theoretical), experimental 
and simulation have been used in computer science. This current study used both formal 
and experimental analysis to validate and study the effectiveness of the developed breast 
cancer risk assessment, survivability and recurrence models and selected individual 
models, as they were conventional methodologies used in research of this magnitude. 
The study also used experimental approaches to examine the efficacy of the proposed 
solutions. 
In this thesis, three experiments were validated with different types of breast cancer 
datasets from different sources. Feature selection algorithms were employed with a 
number of classifiers. Several metrics were also used to measure the classifiers’ 
performance. In addition, R platform was employed to run these experiments as follows:   
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 An ensemble classifier was applied in Chapter 3, which contains Deep Neural 
Network (DNN), Support Vector Machine (SVM), and Random Forest (RF) with 
five feature selection algorithms: CFS_FWD, FCBS, RF, Chi2, and Relief based on 
microarray breast cancer gene expression dataset. Feature selection technique was 
used to reduce the number of unrelated genes in the microarray dataset.  
 The proposed ensemble method with all five features selection methods was 
validated using 10-fold CV. This method obtained the highest accuracy results with 
CFS_FWD feature selector, although the number of genes used was higher compared 
to existing approaches. The experimental results of this study show that 171 genes 
are the most informative genes relating to breast cancer. The “AB020713” gene has 
a higher impact on breast cancer.  
 Random Forest (RF) and Deep Neural Network (DNN) were individually validated 
in Chapter 4, to predict the probability of breast cancer recurrence among patients. 
Holdout technique (70% train data and 30% test data) was applied based on 
Wisconsin Prognostic Breast Cancer (WPBC). In this comparison, RF model showed 
higher accuracy performance than DNN compared to the existing work. 
 In Chapter 5, results of widespread prediction techniques for estimating survivability 
status of breast cancer patients who experienced surgery treatment were stated in 
this study. This study independently validated Deep Neural Network (DNN) and 
Random Forest (RF) methods to train the Haberman’s survival dataset by splitting 
the data into 80% train data and 20% test data. DNN classifier achieved better 
performance than RF in both techniques compared to the existing work.  
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Table 6. 1 Major findings of prediction summary   
Chapter Proposed Method Our Work 
(Accuracy Rate) 
Exsiting Work 
(Accuracy Rate) 
Chapter 3 Ensemble Classifier 
with CFS_FWD 
(DNN,SVM,RF) 
93.95% ± 03.44% 76.05% ± 05.12 % 
Chapter 4 Random Forest (RF) 98.63% ± 2.56% 77.19%± 0.00% 
Chapter 5 Neural Network 
(DNN) 
97.19% 67,70% 
 
6.3 Limitations and Future Work  
Although the proposed techniques focused on the prediction of breast cancer risk 
assessment, the recurrence, and the survivability issues, there is further study that 
requires to be undertaken to investigate these questions even further and expand the 
approaches and experimental results provided in this thesis. To obtain better treatment 
knowledge based on accuracy prediction; this study proposes further research on:  
 Related genes: Several machine learning algorithms have been used for testing 
the classification task. Feature selection was also applied in this study especially 
with microarray gene expression data in risk assessment issue.  Different feature 
selection algorithms could be used again before the classification stage to 
minimise the number of unrelated genes and improve the accuracy of the 
classifier. This is an opportunity for future examination. 
 Classification Accuracy: The present study principally focused on classification 
accuracy as the major criterion for assessing the performance of the proposed 
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methods.  However, future work can concentrate on other challenges such as 
classification phase speed and computational cost.  
 Breast Cancer Dataset: Utilised in recurrence and survivability outcome 
prediction has binary outcomes. This has not been applied to the other datasets 
because the major interest was predicting the recurrence and survivability 
outcome post-surgery treatment within five years or longer. It is envisaged that 
future work could contribute to improve the accuracy of existing methods by 
expanding the databases and increasing the criteria for computing the 
performance of existing approaches. To carry on this research, there should be 
an even broader database. This would help in authenticating the experimental 
results, and also supply the opportunity to build a better approach. Nevertheless, 
that is not entirely up to this researcher, and only time can allow such an 
opportunity to be investigated. 
 Web-based Software Suites: To implement the methods proposed in this study 
requires a knowledge of programming languages such as R language to utilise 
it for one’s own study, the advance of web-based software or a stand-alone 
software suite that applies the proposed methods to make it achievable for 
people who work in the medical field such as doctors, biologists, or 
bioinformaticians to simply perform their jobs.  
 Other types of cancers: While this thesis concentrated on breast cancer issues, 
the proposed methods were employed to predict the risk assessment, recurrence, 
and survivability outcomes for other types of cancer. This research was based 
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on the availability of related microarray gene expression datasets and other 
patients’ datasets which have been collected from various hospitals.  
Although this thesis provides a thorough report of the study on breast cancer risk 
assessment, recurrence, and survivability prediction methods, there are still interesting 
questions that remain to be answered. The increased amount of microarray gene 
expression data and the advent of feature selection and classification approaches show 
an opportunity to achieve a number of biological undertakings, such as predicting breast 
cancer issues, and also represents a challenge in using the obtainable data in the best 
potential approaches. 
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